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ABSTRACT 
The highly toxic fungal metabolite, neosolaniol monoacetate, was 
isolated and purified from cultures of Fusarium sambucinum. Since 
little is known about its toxic properties, the biological effects 
of this trichothecene were compared to those caused by diacetoxy= 
scirpenol .in male Wistar rats. The lesions caused by the two 
toxins were very similar. Chronic exposure to either toxin led 
to a significant decrease (P<0.05) in red blood cell counts and 
a significant increase (P<0.05) in platelet size. The major 
pathological lesions observed were atrophy of the actively dividing 
cells of the bone marrow, thymus, spleen and lymph nodes. 
(iv) 
The reported species difference in T-2 toxin toxicity was investi= 
gated by determining the deacylation rate of T-2 toxin to HT-2 toxin, 
one of the first steps in the detoxification of this trichothecene. 
The high deacylation rate catalysed by rat microsomes correlated with 
the low sensitivity of this species to T-2 toxin, whereas the low 
deacylation rates with cat and monkey microsomes agreed with their 
high sensitivity. In contrast to this, the apparently high toxicity 
of T-2 toxin to humans does not correlate with the high deacylation 
rate observed in human hepatic microsomes. 
Involvement of the UDP-glucuronyltransferases in the detoxification 
of T-2 toxin was studied with rat and pig hepatic microsomes. 
T-2 toxin and two of its metabolites, HT-2 toxin and T-2 tetraol, 
did not appear to act as substrates for these enzymes under the 
in vitro conditions used. 
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1.1 HISTORICAL BACKGROUND 
Mould induced food poisoning, mycotoxicosis·, has posed a threat to 
human health for more than 2000 years. It has been suggested that 
food-borne fungi could have been involved in some of the 10 plagues 
of Egypt during biblical times (1). 
During the Middle Ages St. Anthony's fire, later known as ergotism, 
claimed the lives of many thousands of people in Europe (2). The 
victims contracted the disease after ingesting bread made from rye 
infected with the fungus Claviceps purpurea. The main syndrome 
of this disease was gangrene of the extremities caused by peripheral 
thrombosis of the arteries. Outbreaks of ergotism were recorded 
until recently. In the seventeenth century it was realized that the 
fungi, Claviceps purpurea and~. paspali produced ergot alkaloids 
that were responsible for ergotism. 
During the 1940's a disease known as alimentary toxic aleukia (ATA) 
was recorded in Russia. It has been estimated that hundreds of 
thousands of people died after the consumption of overwintered 
grain infected with the fungi Fusarium sporotrichioides and F. poae (3). 
A major animal mycotoxicosis was reported in 1960 in Britain when 
more than 100000 turkeys died from Turkey X disease caused by 
ingestion of a batch of Brazilian groundnut meal. A blue fluorescent 
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substance, isolated from this meal, was found to be produced by 
Aspergillus flavus and~· niger and this led to the subsequent 
discovery of the aflatoxins (4). The effect of this episode of 
avian disease was to stimulate research into the toxins, myco= 
toxins., produced by food- borne fungi and the possible threats 
these mycotoxins pose to humans and animals. 
Over the last two decades many different mycotoxins have been identi= 
fied and studied with the emphasis largely on the aflatoxins and 
their effects on human and animal health. OIJ'er the past five years 
a definite shift in emphasis has taken place towards investigations on 
the Fusarium toxins and especially the group of sesquiterpene 
toxins known as the trichothecenes. This shift in emphasis can to 
some extent be attributed to the allegations that these toxic 
compounds were used as chemical warfare agents in "Yellow Rain" (5). 
1.2 MYCOTOXICOSES ASSOCIATED WITH TRICHOTHECENES 
The trichothecenes are a group of secondary metabolites produced 
by various fungal genera such as Fusarium, Stachybotrys, Myrothecium, 
Trichoderma and Cephalosporium(6, 7) (Section 1.3). The trichothe= 
cenes produced by Fusaria have received more attention than the macro= 
cyclic trichothecenes produced by the other genera because of their 
involvement in human and animal diseases. 
Certain Fusarium species have been implicated in human diseases 
such as alimentary toxic aleukia (ATA), Urov or Kashin-Beck disease, 
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Akakabi-byo or scabby grain intoxication, and oesophageal cancer (8). 
To date the trichothecenes have been shown to be involved in the 
etiology of only one of these diseases, ATA. 
ATA is a disease that claimed the lives of hundreds of thousands 
of people in the USSR during the final years of the Second World 
War. The victims consumed overwintered grain infected with F. 
sporotrichioides and r. poae (9). ATA is characterized by stomatitis, 
dermatitis, haemorrhage, suppression of the haematopoeitic system, and 
depletion of the bone marrow with resultant leukopaenia, thrombo= 
cytopaenia and immunosuppression (3, 8). 
Cultures ofr. sporotrichioides and r. poae isolated from the over= 
wintered grain, when administered to various animal species, 
successfully reproduced the symptoms of ATA in cats and monkeys. 
The trichothecene, T-2 toxin, isolated from these cultures 
produced the characteristic ATA symptoms in cats (10), substantia= 
ting the role of T-2 toxin in the etiology of ATA. 
Outbreaks of Akakabi-byo or scabby grain intoxication of humans 
have been reported in the USSR and Japan. In the USSR the outbreak 
resulted from the consumption of bread made from scabby rye infected 
by r, graminearum. The symptoms observed included headache, vertigo, 
shivering chills, nausea, vomiting and visual disturbances. In 
Japan sporadic occurrences of scabby wheat, barley, oats, rye and 
rice caused by r. graminearum were frequently associated with out= 
breaks of human mycotoxicoses characterized by anorexia, nausea, 
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vomiting, headache, abdominal pain, diarrhea, chills, giddiness and 
convulsions. There were also reports that F. sporotrichioides 
may be involved in Akakabi-byo (8). ~- graminearum and~- sporo= 
trichioides have been shown to produce various trichothecenes 
such as deoxynivalenol, nivalenol, fusarenon-X, diacetoxyscirpenol 
(DAS), neosolaniol and T-2 toxin (11). Although deoxynivalenol 
and nivalenol are known to occur naturally in scabby grains in 
Japan, these two trichothecenes have not been directly implicated 
in an actual case of human mycotoxicosis. It is thus not known 
whether nivalenol and/or deoxynivalenol are responsible for the 
clinical symptoms or whether other toxins or factors are involved (8). 
The Fusaria have also been associated with various animal myco= 
toxicoses with haemorrhagic, estrogenic, emetic and feed refusal 
effects as well as with fescue foot, bean hulls poisoning and 
equine leukoencephalomalacia. The haemorrhagic, feed refusal and 
emetic syndromes are the only ones where the trichothecenes have 
been shown to play a role (8). 
The haemorrhagic syndrome is associated with the ingestion of 
moldy cereals contaminated with F. sporotrichiOides This 
disease is characterized by bloody diarrhea, necrotic oral lesions, 
haemorrhagic gastro-enteritis and extensive haemorrhages in many 
organs and has affected cattle, pigs and poultry. Many of the 
pathological lesions observed in field outbreaks have been 
reproduced experimentally with cultures of toxic strains of I· sporo= 
trichioides, crude extracts of cultures and crystalline trichothe= 
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cenes such as T-2 toxin and DAS (8). 
Sporadic field outbreaks of feed refusal and emetic syndrome in pigs 
are linked with the ingestion of F. graminearum infected cereals, 
especially corn and barley. It has been shown that the trichothe= 
cene, deoxynivalenol, occurs in cereals infected by!· graminearum 
at levels capable of inducing characteristic clinical signs of 
these syndromes under experimental conditions. It is possible that 
deoxynivalenol alone is not responsible for the feed refusal syndrome 
and that other factors may be involved (8, 12). 
1.3 THE PRODUCTION OF THE TRICHOTHECENES 
The trichothecene mycotoxins are produced by various fungal genera 
from two families of imperfect fungi, Dematiaceae and Moniliaceae (7). 
1.3.1 Trichothecene Producers from the Family Dematiaceae 
The family Dematiaceae have two trichothecene producing genera, 
Myrothecium and Stachybotrys. Two Myrothecium species are known to 
produce trichothecenes. M. verrucaria produces verrucarin A, B, J 
(6, 7, 13) and the trichoiverroids (13). (Section 1.4). The 
trichoiverroids include trichodermadiene, trichoverrins A and B, 
roridin L-2 and trichoverritone. ~- roridum produces the roridins 
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(A, D, E and H) (6, 7, 13) and also roridin L-2, trichoverritone, 
16-hydroxytrichodermadienediols A and B, and 16-hydroxyroridin L-2 (13). 
Only one species from the genus Stachybotrys, ~. atra, is known 
to produce trichothecenes (6, 7). The macrocyclic trichothecenes 
produced by this species are known as satratoxins C, D, F, G and H 
(7). 
1.3.2 Trichothecene Producers from the Family Moniliaceae 
The trichothecene producing genera in this family are Fusarium, 
Cephalosporium, Trichoderma and Trichothecium (7). The genus 
Fusarium has received the most attention because of its involvement 
in human and animal mycotoxicoses (7, 8, 13). The Fusaria occur 
widely in nature on many hosts and substrates. They are of the 
most commonly occurring fungi and many of the species are para= 
sitic to higher plants, causing severe economic losses (6, 7). 
The taxonomy of the genus Fusarium is complex as different classi= 
fication systems are used in different countries. Wollenweber 
and Reinking (14) were the first to publish a Fusarium classifi= 
cation system. Snyder and Hansen reduced the number of Fusarium 
species from 65, according to Wollenweber and Reinking, to 9. 
Nelson et al (15) recently published a classification system 
that includes the advantages of the different systems, as well as 
their own suggestions, to aid in the practical identification of 
the Fusaria. This classification system comprises 15 Fusarium 
species reported to produce trichothecenes (8). The Fusaria 
produce both type A arld type B trichothecenes (Section 1.4.2). 
These species are E· nivale, F. sporotrichioides, ~- poae, I· tri= 
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cinctum, r. avenaceum, r. semitectum, r. equiseti, r. acuminatum, 
F. sambucinum, r. graminearum, r. lateritum, F. moniliforme, 
F. oxysporum, F. solani and F. culmorum. 
In the genus Cephalosporum there is only one species known to 
produce trichothecenes (7). Crotocin and crotocol are produced 
by~· crotocinigenum (6, 7). The genus Cephalosporum occurs wide ly 
in nature, both as saprophites and occassionally as parasites on 
plants and animals (7). 
In the genus Trichoderma, !· viride and!· polysporum are known to 
produce trichodermin and trichodermol (6,7). Trichothecium roseum, 
the only species in the genus Trichothecium to produce trichothe= 
cenes, produced trichothecin and trichothecolone (6, 11). 
1.4 CHEMICAL NATURE OF THE TRICHOTHECENES 
1.4.1 Chemical Properties 
There are more than 40 naturally occurring trichothecenes and they 
all have a basic tetracyclic sesquiterpene structure (6, 11). The 
structure and numbering system is shown in Figure 1.1. Most of 
the trichothecenes have an epoxide ring at C-12,13 and a double 
bond at C-9,10 and are therefore called 12,13-epoxytrichothec-9-
enes (6, 7). The naturally occurring mycotoxins have a minimum of 
six chiral centres at 2, 4, 5, 6, 11 and 12. For the elucidation of 





Fig. 1.1 Structure and numbering system of the trichothecenes 
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Fig. 1.2 Stereochemical configuration of DAS. 
reference point and was assigned the a-configuration. Figure 1.2 
represents the stereochemical structure of DAS. The presence of the 
9,10 double bond leads to a 1,2 diplanar conformation for the 
six membered A ring, which is typical of substituted cyclohexanes . 
six-membered oxa-ring B adopts a chair configuration, and the 
five membered ring Can envelope form (11). 
The trichothecenes are usually colourless, crystalline compounds. 
They are generally soluble in organic solvents such as alcohol, 
acetone, ethyl acetate and chloroform, but are only slightly soluble 
in water (11). 
The group A and C trichothecenes (Section 1.4.2) do not show any 
absorbance or fluorescence in the ultraviolet or visible regions of 
the spectrum. This is due to the absence of any conjugated double 
bonds (16). The group B trichothecenes show absorbance at 215-226 
nm due to the presence of a carbonyl group and group D at 195-263 
nm due to conjugated double bonds in their macrocyclic structure. 
1.4.2 Structural Classification of the Trichothecenes 
The trichothecenes have been classified into four groups according 
to their chemical characteristics. Groups A and B differ mainly 
by the presence (B) or absence (A) of a carbonyl function at C-8. 
Examples of trichothecenes belonging to group A are T-2 toxin, 
diacetoxyscirpenol, scirpentriol and trichodermin (Table 1.1) 
while nivalenol, fusarenon-X, deoxynivalenol and trichothecin belong 
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to group B (Table 1.2). Group Chas only one member, namely 
crotocin (Table 1.3). Group D consists of compounds that possess a 
macrocyclic ester bridge between carbons 4 and 15. Examples of 
this group are the verrucarins and roridins (Table 1.4) (17). 
TABLE 1.1 STRUCTURES OF GROUP A TRICHOTHECKNES 
COMPOUND Rl R2 R3 R4 R5 
T-2 toxin OH OCOCH3 OCOCH3 H OCOCH2 CH ( CH3) l 
HT-2 toxin OH OH OCOCH3 H OCOCH2 CH ( CH3 )2 
T-2 triol OH OH OH H OCOCH2 CH ( CH3 )2 
T-2 tetraol OH OH OH H OH 
Diacetoxyscir= OH OCOCH3 OCOCH3 H H 
penol 
Neosolaniol OH OCOCH3 OCOCH3 H OH 
Neosolaniol OH OCOCH 3 OCOCH3 H OCOCH 3 
monoacetate 
Trichodermin H OCOCH 3 H H H 
10 
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TABLE 1. 2 STRUCTURES OF GROUP B TRICHOTHECKNES 
COMPOUND Rl R2 R3 R4 
Trichothecin H OCOCH==CHCH 2 H H 
Nivalenol OH OH OH OH 
Fusarenon-X OH OCOCH3 OH OH 
Deoxynivalenol OH H OH OH 




TABLE 1.4 STRUCTURES OF GROUP D TRICHOTHECKNES 
COMPOUND R Rl R2 
0 
\\ 
Verrucarin A -CHOHCHCH3 CH2 CH2 0C - H H 
Verrucarin B 
0 0 / 1 \\ 
-CH- H3 CH2 CH20C - H H 
10, I 




H H Satratoxin F -CH-C......_,__ (0 
OH 
cP'<\CH3 
~ Satratoxin H -CH ==·c......____ (o H H I 
OH CHOHCH3 
1.5 THE BIOLOGICAL ACTIVITY OF THE TRICHOTHECENES 
1.5.1 Toxicity 
The trichothecenes have been shown to be toxic to a number of 
different animal species. The LD 50 values depend on the route of 
administration and the animal species (6, 18). For example, the 
LD50 for T-2 toxin is 5.2 mg/kg bodyweight in mice when administered 
i.p. and 10.5 mg/kg when administered p.o. (18, 19). Of the A 
type trichothecenes T-2 toxin is the most toxic to animals while 
nivalenol is the most toxic type B trichothecene (18). Verrucarin 
A and J are the most toxic of the type D trichothecenes and are 
even more toxic than T-2 toxin (18). More studies have been performed 
on the biological action of the type A and B trichothecenes than 
on the other types because of their more frequent natural occurrence. 
The toxicity of the 12,13-epoxytrichothec-9-enes depends largely 
on the nature of the substituents on the cyclic skeleton of the 
molecules. The removal of the C-8 isovaleryl residue in T-2 toxin 
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(LD50 = 4.97 mg/kg), by hydrolysis to form a hydroxyl group (neosolaniol; 
LD50 = 24.87 mg/kg) decreases the toxicity, whereas its replacement 
by an acetate group (neosolaniol monoacetate (NMA); LD 50 = 3.22 mg/kg) 
increases the toxicity to broiler chicks. The toxicity of T-2 
toxin to broiler chicks was also reduced by deacylation to HT-2 
toxin (LDs0 = 7.22 mg/kg) and T-2 tetraol (LD 50 = 33.79 mg/kg) (20). 
A wide variety of symptoms are observed in experimental animals when 
treated with trichothecenes including ataxia, diarrhea, haemorrha= 
ging, emesis, anorexia, hypothermia and disturbances of the central 
nervous system (10, 21-26). 
1.5.2 The Effect of the Trichothecenes on the Immune System 
1.5.2.1 The effect on lymphoid tissues 
Mice treated with T-2 toxin, fusarenon-X, neosolaniol, HT-2 toxin 
or DAS suffered from atrophy of the thymus (27-30) together with a 
reduction in weight of the thymus (30, 31). Atrophy was also 
reported in cats, rats and guinea pigs treated with fusarenon-X 
(28) while T-2 toxin produces similar results in avians (32). 
The cell numbers in mouse thymus are decreased by T-2 toxin treat= 
ment (33) while major changes occur in the cortical region (34). 
This region of the thymus contains many lymphocytes. At a 
cellular level it has been shown that fusarenon-X treatment results 
in karyorrhexis of the actively dividing cells (28). 
As in the thymus, the major lesion seen in the spleens of various 
species is atrophy of the lymphoid tissue after treatment with 
T-2 toxin (10, 21, 27, 31, 35, 36). Fusarenon-X and DAS have 
similar effects on the spleen (21, 28, 37). 
Administration of T-2 toxin to cats results in the formation of 
amyloid material in the spleen. This could indicate that T-2 toxin, 
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like other cytotoxic drugs, may cause an increase in amyloid inducing 
factors from decaying lymphoid cells (10). In mice, treatment with 
fusarenon-X results in an increase in non-lymphocytic cells in 
the spleen (37). It would thus appear that trichothecenes affect 
the lymphoid tissue in spleen in two ways, namely by reducing 
lymphocytic cells and by increasing non-lymphocytic cells. 
Karyorrhexis is observed in the spleens of animals treated with 
trichothecenes (28, 35) and pyknotic nuclei are noticed in some 
animals (35). 
The treatment of animals with trichothecenes results in atrophy 
of the lymph nodes (27, 36, 38-40) and regular haemorrhaging is 
noticed (10, 22), primarily affecting the mesenteric lymph nodes 
(10). T-2 toxin seems mostly to affect actively dividing cells 
(39) and in swine pyknotic nuclei and karyorrhexis of cells in 
the lymph nodes are observed (35). 
1.5.2.2 The effect on antibody synthesis 
Treatment of mice with T-2 toxin and DAS inhibits antibody 
synthesis after immunization with sheep red blood cells (30, 34, 
41). Fusarenon-X decreases the anti-DNP, IgE and IgG formation 
in mice (37). Similar effects are observed in mice treated with 
deoxynivalenol (42). 
Inhibition of antibody synthesis appears to be due to a direct 
effect of the trichothecenes on the antibody producing cells. 
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In monkeys, T-2 toxin causes the reduction of the B-cell population 
(43). T-2 toxin also causes suppression of splenic B-cell proli= 
ferative responses and reversible inhibition of B-cell stimulation 
by mitogens in mice, lambs and pigs (44-47) while it is a lso 
cytotoxic to lymphocyte cell cultures (46). 
1.5.2.3 The effect on cell-mediated responses 
Evidence for the effect of the trichothecenes on the cell-mediated 
response was provided when it was shown that T-2 toxin and DAS 
prolong the period required for skin graft rejection in mice (30, 
48). 
Another immune response mediated by sensitized T-lymphocytes is 
termed delayed hypersensitivity. This term merely describes the 
slow appearance of secondary responses in the skin after immuni= 
zation (49). In mice T-2 toxin enhances the delayed hypersensitivity 
response (48, 50) and this can be explained by the preferential 
inhibition of the proliferation of a subset of T-lymphocytes which 
otherwise reveal suppressor functions (38, 48). 
As with humoral immunity, the lymphocytes responsible for cell-
mediated immunity are directly affected by the trichothecenes. 
Fusarenon-X causes suppression of mouse lymphocyte functions in 
vivo and in vitro. This inhibition is much more pronounced with 
T-cells than with B-cells (37). 
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1.5.3 The Effect of the Trichothecenes on the Haematopoeitic 
System 
1.5.3.1 The effect on red blood cells 
The treatment of rats and cats with DAS and T-2 toxin results in a 
decrease in red blood cell levels (10, 21, 39). Red blood cell 
levels in laying hens and chickens are however not affected by 
T-2 toxin treatment (51, 52). In swine, neither i.v. administered 
T-2 toxin nor dietary DAS has an effect on red blood cell levels 
(51, 52). T-2 toxin causes haemolysis in in vitro experiments 
by a mechanism, similar to that induced by H2 0 2 and polyoxyethylene 
surfactants, involving a free radical reaction mechanism ( 53). 
Other studies support the hypothesis that T-2 toxin induces 
haernolysis by interacting with the cell membrane (54). 
1.5.3.2 The effect on white blood cells 
The white blood cell population is more susceptible to the effect 
of the trichothecenes than red blood cells (55). Treatment of 
several animal species with T-2 toxin results in a decrease in 
their white blood cell counts (31, 38, 39, 47). Some reports 
however claim that T-2 toxin has no effect on white cell numbers 
in swine (35). DAS causes a reduction of white blood cell numbers 
in rats and young chickens (21, 40), while those of swine are 
unaffected (56). Administration of fusarenon-X and neosolaniol to 
mice results in a temporary leukocytosis (31). 
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The different subpopulations of white blood cells are affected 
differently by the trichothecenes. Monkeys develop leukocyto= 
paenia after T-2 toxin treatment due to a reduction in the number 
of polymorphonuclear white blood cells, while the lymphocyte 
numbers remain unchanged (36). T-2 toxin has a similar effect on 
calves as on monkeys (55). In young chickens treatment with T-2 
toxin and DAS results in rapid necrosis of lymphocytes (40). 
1.5.3.3 The effect on blood platelets 
The administration of T-2 toxin to mice, monkeys, rabbits and 
guinea pigs results in a reduction in platelet number (31, 36, 
57, 58), while in calves T-2 toxin has no effect on the platelet 
number (55). Terminally ill cancer patients treated with DAS 
as an anti-neoplastic agent developed thrombocytopaenia (59). 
Two other trichothecenes, fusarenon-X and neosolaniol, also 
cause a reduction in platelet number in mice (31). 
1.5.3.4 The effect on blood coagulation 
T-2 toxin increases the blood coagulation times in cows, rats, 
rabbits, lambs and guinea pigs (22, 44, 58, 60, 61). The 
coagulation patterns of plasma from T-2 toxin-treated guinea pigs 
diluted with plasma from untreated animals point to a deficiency 
of coagulation factors as the principle cause of prolonged 
clotting times (58). 
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T-2 toxin decreases different coagulation factors in various animal 
species. In rabbits, treatment with T-2 toxin results in a 40% 
decrease in the activities of factors VII, VIII, IX, X and XI 
(57). Factors VII, IX, X and XI and fibrinogen values are decreased 
in calves (62). In chickens, treatment with T-2 toxin results 
in a decrease in the concentrations of factors VII, X, prothrombin 
and fibrinogen (63). 
The trichothecenes have a direct inhibitory effect on the 
aggregation of platelets. When either collagen or ADP is used as 
aggregating agent in vitro, T-2 toxin, HT-2 toxin, DAS and deoxy= 
nivalenol, in decreasing order of potency, inhibit the aggregation 
of bovine platelets (64, 65). A dose related inhibition of human 
platelet aggregation by T-2 toxin has also been reported (66). 
Thromboxane A2 , which is involved in aggregation of platelets, 
is spontaneously and rapidly converted to thromboxane B2 which is 
completely inactive. Thromboxane B2 release from collagen-stimu= 
lated platelets is decreased in the presence of trichothecenes 
(64-66). It therefore seems that the trichothecenes somehow 
inhibit the synthesis of thromboxane A2 or the release of 
thromboxane B2 • T-2 toxin changes platelet membrane permeability 
(66) and could change the secretion of thromboxane B2 • 
1.5.3.5 The effect on the bone marrow 
Bone marrow is severely affected in animals treated with trichothe= 
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cenes. T-2 toxin, HT-2 toxin, DAS, neosolaniol and fusarenon-X 
affect the actively dividing cells in bone marrow of mice, cats, 
guinea pigs, young chickens and rats (38-40, 52, 67, 68) while 
those of swine are not affected by T-2 toxin treatment (35). 
The pathological lesions in the bone marrow are cellular degene= 
ration (28, 68), hypoplasia (69, 70) and karyorrhexis (28). All 
cells in the bone marrow are not affected to the same extent by 
the trichothecenes. In mice erythropoeisis is more susceptible 
to T-2 toxin than myelopoeisis and thrombopoeisis (69, 70). In 
rats, myeloid cells are more susceptible to T-2 toxin than lymphoid 
cell lines (67). 
1.5.3.6 The effect on serum cholesterol and hematocrit levels 
Cholesterol levels increase in the serum of cows, rats, laying hens 
and broiler chicks after T-2 toxin treatment (22, 51, 61, 71, 72). 
Swine and terminally ill cancer patients treated with T-2 toxin and 
DAS respectively, show no changes in their serum cholesterol (35, 59). 
The hematocrit of monkeys, broiler chicks, rabbits, calves and 
guinea pigs decreases after T-2 toxin administration (36, 55, 58, 60, 
71) while DAS treatment has no effect on the hematocrit level in 
swine (56). This decrease in hematocrit correlates with the 
decrease in red blood cells observed in animals treated with the 
trichothecenes (Section 1.4.3.1). 
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1.5.4 The Effect of the Trichothecenes on the Hepatobiliary 
System 
The livers of animals appear to be prime targets for the action of 
trichothecenes. Chickens administered T-2 toxin i.m. present 
with enlarged and haemorrhagic livers (73) while monkeys and rats 
treated with DAS show a decrease in liver weight (21). 
The lipid composition of liver is influenced by trichothecenes. 
Albino rats receiving dietary T-2 toxin have small areas of focal 
fatty change in their livers (53) and in calves fatty degeneration 
is observed after T-2 toxin treatment (74). Laying hens and rats 
treated with deoxynivalenol and T-2 toxin, respectively, have increased 
lipid levels in the liver (75, 76). The increased lipid content 
consists mainly of triglycerides, free cholesterol and phosphatidyl 
choline. Studies with [l- 1~C] acetate suggest that the synthesis of 
these lipid components is reduced in the rat livers. Despite this 
decreased synthesis of lipids, the total lipid content increases, 
suggesting impaired secretion of lipids from the liver to blood (75). 
Microscopical examination of affected livers reveals cytoplasmic 
degeneration of cells (77) as well as irregular cell nucleus size 
in the liver (21). Liver cell damage is also indicated by changes 
in the levels of serum enzymes. The increase in the levels of 
isocitrate dehydrogenase, alanine transaminase, aspartate transami= 
nase and glutamate pyruvate transaminase in animals treated with 
T-2 toxin and DAS indicates damage to the hepatobiliary system 
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(56, 73). In animals where the liver is not affected by the 
trichothecenes, these enzyme levels are unchanged (35, 52, 56, 73). 
Animals treated with T-2 toxin and DAS however show a decrease in 
alkaline phosphatase activity (22, 36, 73, 78), probably due to 
impaired synthesis. 
An enlarged gall-bladder is observed in chickens and hens receiving 
T-2 toxin (72). In young chickens T-2 toxin and DAS cause rapid 
necrosis of the extrahepatic biliary tract mucosa and of the gall 
bladder mucosa (40) as well as bile duct proliferation in rats and 
chickens (21, 40). 
1.5.5 The Effect of Trichothecenes on the Gastrointestinal Tract 
Treatment of rats, cows, mice and guinea pigs with T-2 toxin and 
DAS results in haemorrhaging of the intestine (21, 22, 68, 69). 
Very high doses of T-2 toxin result in the shedding of the intesti= 
nal mucosa in mature trout (79). Excessive damage to the actively 
dividing cells of the intestinal mucosa is observed in various 
animal species treated with fusarenon-X, neosolaniol, T-2 toxin and 
DAS (27-29, 38-40). Karyorrhexis, mitotic injury and cellular 
degeneration occurs in some animals (28, 29, 35) while others 
show hyperplasia of the mucosa (56, 70). 
Trichothecenes also affect the intestinal crypts and villi. Swine 
and young chickens treated with T-2 toxin develop pyknotic nuclei 
and karyorrhexis of the crypt cells in the jejenum and ileum (35, 40). 
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In mice fusarenon-X causes a shortening of the intestinal villi 
(80). 
One of the symptoms of trichothecene mycotoxicosis, diarrhea, was 
studied in fusarenon-X treated mice (80). As fusarenon-X 
inhibits peristalsis of the intestine, increased fluidity of the 
intestinal contents is thought to be responsible for the watery 
diarrhea. Fusarenon-X increases the permeability of the intestinal 
lumen. 
1.5.6 The Effect of Trichothecenes on the Cardiovascular System 
Oral and i.v. administration of T-2 toxin to rats results in an 
increase in blood pressure (25, 61, 81) followed by a decrease 
in blood pressure to below normal values as the rats near death 
(61, 81). As T-2 toxin causes no change in the blood pressure of 
pithed rats, animals with their central nervous system destroyed, 
it seems that the effect on the blood pressure occurs via the 
effect of T-2 toxin on the central nervous system (81). Fusarenon-X 
increases the blood pressure in mice, but in rats the blood pressure 
decreases (24). 
In rats and guinea pigs, T-2 toxin causes an increase in heart rate 
followed by a decrease shortly before death (61, 81). Similar 
results were obtained with cats and guinea pigs treated with fusarenon-X 
(28). Fusarenon-X however has no effect on the heart rate of mice 
(24). T-2 toxin has no effect on the heart rate of pithed rats (81) 
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implying that the heart rate is affected via the central nervous 
system. T-2 toxin however has a mild but irreversible effect on the 
heart rate of isolated perfused rat hearts (82). In guinea pigs 
T-2 toxin causes myocardial conduction abnormalities (83) and thus 
the effect of the trichothecenes on the heart rate seems to be mediated 
by disturbances in the conduction of impulses. 
Rats treated with T-2 toxin develop severe cardiovascular lesions 
(84, 85). The lesions in the heart consisted of interstitial 
oedema, focal cellularity and damage to single or groups of 
myocytes. After 10 daily administrations of T-2 toxin cardiomyo= 
phathy-like changes are seen with hypertrophy, focal fibrosis and 
abundant cellularity, especially in the subendothelial regions of 
the left ventricle (85). 
The vasculature of animals is also affected by the trichothecenes. 
In rats T-2 toxin damages the vascular epithelium (24) and in a 
bovine ear perfusion system it results in a dose dependent vasocon= 
strictor response (86). The results from the ear perfusion system 
indicate that the natural defense mechanisms of the animal to 
stress or the response to stressor substances, such as histamine 
and norepinephrine, is impaired by T-2 toxin. 
1.5.7 The Dermal Toxicity of Trichothecenes 
The application of DAS, T-2 toxin and neosolaniol to the skin of 
various animal species results in crust formation that heals 
gradually (21, 22, 27, 79, · 87). Haemorrhages are also observed 
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after the application of T-2 toxin and neosolaniol to the skin of 
mice (87). Low doses of T-2 toxin and DAS on mouse and rabbit skin 
result in a non-specific acute dermal inflammatory reaction that 
is characterized by hyperaemia, oedema and neutrophil exudation, 
and variable degrees of necrosis of the epidermis (87). The 
subcutaneous application of nivalenol and fusarenon-X results in 
oedamatous change with degeneration and necrosis of the subcutaneous 
tissue (88). The reaction of the trichothecenes on the skin of 
animals has been used in the detection of these toxic compounds. 
1.5.8 The Carcinogenicity of the Trichothecenes 
Marasas et al (79) observed that T-2 toxin fails to induce hepatomas 
in trout and rats. There are, however, reports that T-2 toxin causes 
hepatomas and neoplastic lesions in rats and mice (25, 89. 90). 
The trichothecenes are not mutagenic in the Salmonella typhimurium 
mutagenicity test but cause chromosomal aberrations in guinea 
pigs (90). The overall impression is that the trichothecenes 
are not carcinogenic per se but can influence carcinogenesis 
by reducing the immunological capability (90; section 1.4.2). 
1.5.9 The Effect of Trichothecenes on Macromolecular Synthesis 
The trichothecenes are very potent and specific inhibitors of 
protein synthesis (91) in a broad spectrum of organisms including 
fungi, plants and animals (92). The mode of action of inhibition 
has been studied extensively and it is now accepted that they act 
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mainly by interfering with the active centre of the ribosomal 
peptidyl transferase thereby preventing the completion of the 
ribosomal cycle (91, 93-97). Two mechanisms have been proposed -
in the one instance, the trichothecenes only bind to the ribosome 
at certain stages of the ribosomal cycle, while in the other they 
bind throughout the ribosomal cycle, only interfering with peptidyl 
transferase when the ribosome assumes certain unique configurations 
during the cycle (92). 
The ability of the trichothecenes to inhibit various stages of 
protein synthesis has been used to classify them into three 
categories, namely inhibitors of chain initiation (I), inhibitors 
of chain elongation (E) and/or inhibitors of chain termination (T). 
(90, 95, 96, 98, 99). 
The chain initiation inhibitors are further divided into two 
groups: those that only inhibit the function of intact ribosomes 
(I 2 ) and those that can also prevent formation of the initiation 
complex (I 1 )(90, 96). 
The E or I type behaviour is dependent upon the concentration of 
some trichothecenes. Thus they are divided into classes of I type 
showing partial E type behaviour at high concentrations (I 2 -E) and 
E-type showing I type behaviour at low concentrations (E-I 2 ) (90, 
96). Table 7 gives examples of the different classes of inhibitors. 
The termination inhibitors are either unsubstituted or carry only 
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a small substituent at the C-4 position. Trichothecenes with an 
ester group at C-4 or other positions are normally elongation 
inhibitors. Introduction of an ester function on the C-15 position 
will make a compound that shows pure E-type behaviour become an 
E-I 2 type compound. Compounds show type I behaviour if, in 
addition to an ester at C-15, either the C-3 or C-4 alcohol groups 
are acylated (88, 98-100). 
The trichothecenes have also been shown to inhibit DNA synthesis in 
intact cells (90, 101), although no effect on DNA polymerases and 
thymidine kinase in vitro is observed. It seems that DNA synthesis 
inhibition is a secondary effect to protein synthesis inhibition (90). 
TABLE 1.5 Classes of protein synthesis inhibitors 
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1.6 METABOLISM OF THE TRICHOTHECENES 
l.61.l Xenobiotic Metabolism 
Humans and animals are frequently exposed to foreign compounds, 
xenobiotics, that can enter their bodies and exert harmful 
effects. To reduce the harmful affects, various defense mechanisms 
exist, including the so-called drug metabolising enzyme systems, 
whereby the excretion of the compounds is fascilitated (102). 
The drug metabolising enzymes occur in tissues such as kidneys, 
skin and intestine but the liver, because of its size and the 
relatively high concentrations of these enzymes, is the major 
site of drug metabolism. Some compounds may however not be 
metabolised primarily by the liver, depending on factors such as 
structure of compounds, enzyme specificity and site of entry into 
the body. 
Drug metabolism is arbitrarily divided into two phases. The reactions 
occurring in phase 1 usually involve the conversion of a hydrophobic 
xenobiotic to a more polar, hydroxylated molecule (102). Phase 2 
reactions are conjugation reactions whereby polar molecules are 
attached to a compound or to a hydroxylated product from a phase 
1 reaction. These highly polar water soluble conjugates can 
then readily be excreted in the bile or urine (102). 
The major phase 1 reactions are oxidation, reduction and hydrolysis. 
Enzymes involved in oxidation include cytochrome P~50 , azo-reduc= 
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tases and nitroreductases. The major enzymes catalysing conjugation 
reactions in phase 2 of drug metabolism are glutathione S-trans= 
ferases, sulfotransferases and UDP-glucuronyltransferases. 
A wide spectrum of compounds are capable of inducing the synthesis 
of drug metabolising enzymes, e.g. medical drugs, carcinogens, 
pesticides, cigarette smoke and various environmental pollutants. 
In drug metabolism, induction is defined as an increase in the 
total activity of the enzymes. Phenobarbital and 3-methylcholanthrene 
are two of the best known and most effective inducing agents. Pheno= 
barbital can induce a wide variety of enzymes such as cytochrome 
P450 , monoamine oxidase, epoxide hydratase, glutathione S-trans= 
ferases and UDP-glucuronyltransferases. 3-Methylcholanthrene 
induces cytochrome P 448 (a form of cytochrome P 450 with different 
specificity), epoxide hydratase, UDP-glucuronyltransferases and 
glutathione S-transferases. Although some substrates of the drug 
metabolising enzymes can act as inducers it is not necessary for 
a substance to be a substrate to have inducing activity (102). 
1.6.2 Metabolism of T-2 toxin 
Hayes and Schiefer (69) observed that mice receiving dietary T-2 
toxin initially showed signs of inhibition of haematopoeisis 
which they later overcame while still consuming the food containing 
T-2 toxin. When rats were treated with phenobarbital before 
receiving T-2 toxin the mortality rate decreased (61). These 
observations pointed to an inducible enzyme system that is 
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involved in the detoxification of T-2 toxin. 
Tissue distribution studies were performed in mice (28, 77), 
chickens (103) and swine (104) using [3 H] T-2 toxin or fusarenon-X. 
Radioactivity determinations in various tissues, excreta and blood 
of mice treated with [3 H] T2-toxin (p.a.) (77) indicate that there 
is no accumulation of radioactivity in any of the organs. The 
bile of these animals registers the highest specific radioactivity, 
indicating that T-2 toxin and/or its degradation products are 
mainly excreted via the liver and the biliary excretory system. 
Of the total dose of radioactivity, 57% is recovered in the faeces 
and 12% in the urine. 
The radioactivity level in the blood after p.a. administration 
shows the occurrence of two peaks after 1 hour and 24 hours, 
respectively. The first peak is thought to be due to the rapid 
uptake of the toxin and the second peak is considered to originate 
from the reabsorption of T-2 toxin and/or its degradation products 
excreted via the bile into the intestine (77). Tissue distribution 
studies in chickens (103) and swine (104) after p.a. dosing of 
[
3 H] T-2 toxin give results similar to those observed in mice (77). 
The maximum levels of radioactivity in tissues of mice occur 30 
minutes after s.c. injection of [3 H] fusarenon-X (28). As with 
T-2 toxin no specific accumulation in any tissue is observed, while 
the major route of excretion seems to be via the kidneys in the urine. 
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Ellison and Kotsonis (105) studied the in vitro metabolism of T-2 
toxin and observed that when it is incubated with the post-mitochon= 
drial supernatant of bovine or human liver, HT-2 toxin is formed 
by the action of liver esterases which remove an acetyl group 
from C-4 on the T-2 toxin molecule. The conversion of T-2 toxin 
to HT-2 toxin using post-mitochondrial supernatant prepared from 
rat liver was demonstrated by Ohta et al (106). They followed 
the conversion gas chromatographically and showed that the amount 
of HT-2 toxin formed is equal to the decrease in the amount of 
T-2 toxin. When HT-2 toxin is incubated with hepatic post-
mitochondrial supernatant, no decrease in the amount of HT-2 toxin 
is observed. The subcellular fraction with the highest deacylating 
activity is the microsomal fraction (106, 107). Kinetic analysis 
of the formation of HT-2 toxin reveals that the Km value for the rat 
enzyme is 2.7 x 10- 4 M (106). 
Ohta et al (106) also investigated the possible role of cytochrome 
P 450 in the formation of HT-2 toxin. Eserine and diisopropylphos= 
phofluoridate (DFP), known inhibitors of esterases, completely 
inhibit the formation of HT-2 toxin, confirming that a microsomal 
esterase catalyzes this reaction and that cytochrome P 450 is not 
involved. In the presence of microsomes and NADPH a decrease in 
the formation of HT-2 toxin is observed (106) which can be explained 
by the formation of 3'hydroxy T-2 toxin and 3'hydroxy HT-2 toxin (108). 
The specificity of the microsomal esterases was examined by Ohta 
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et al (106) by incubating various trichothecenes with microsomes 
prepared from rat and rabbit liver. They concluded that the 
enzyme attacks the C-4 acetyl residue of the trichothecenes and 
that the nature of the substituents at C-3 and C-8 influences the 
enzymatic hydrolysis of the C-4 acetyl residue. A hydrophobic 
group in the C-8 position appears to be essential for deacylation 
at C-4. 
Yoshizawa (110) found that by incubating T-2 toxin with post-
mitochondrial supernatant from rat liver for 60 minutes, T-2 toxin 
is completely metabolised to four metabolites, HT-2 toxin, T-2 
tetraol and two unknown metabolites. When HT-2 toxin is incubated 
with the post mitochondrial supernatant, T-2 tetraol and the 
two unknown metabolites are formed, suggesting that the two unknown 
metabolites and T-2 tetraol are formed from T-2 toxin via HT-2 toxin. 
Yoshizawa (110) proposed the following pathways for T-2 toxin 
metabolism: 
Major pathway HT-2 toxin 
/ ~ 
~ep 1 Step 2 
T-2 toxin ~deacetylneosolaniol 
Minor pathway 
~eosolaniol~ l Step 3 
T-2 tetraol 
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The reactions rates of the different steps were investigated by 
Yoshizawa and Sakamoto (107) using different subcellular fractions 
of the liver. The deacylation rates of steps 1 to 3 differ conside= 
rably in the different species, as shown below, when using post-
mitochondrial supernatant. 
SPECIES (nmol product/mg/10 min) 
STEP 1 STEP 2 STEP 3 
Rabbit 128.5 0.7 3.6 
Rat 31.4 0.8 0.4 
Swine 19.3 0.1 1. 7 
Cow 4.9 0.2 0.3 
Chicken 3.3 0.0 0.0 
They also indicated that step 1 occurs in microsomes, step 2 in cyto= 
sol and step 3 in both microsomes and cytosol. Different enzymes 
appear to catalyze the different steps as the esterase inhibitor, 
eserine, affects the deacylation steps differently (107). 
The proposed pathway shown in the diagram above can be elaborated 
by including the role of cytochrome P 450 , as demonstrated by 
Yoshizawa et al (108). 
3'hydroxy T-2 toxin T-2 toxin 





Cell culture studies indicated that Chinese hamster ovary (CHO) cells 
metabolise T-2 toxin primarily to HT-2 toxin while African green 
monkey (VERO) cells form an unknown metabolite, more polar than 
T-2 toxin (111). O'Brien et al (112) observed that T-2 toxin 
is rapidly metabolised to HT-2 toxin by rat hepatocytes, and then 
more slowly to a multiple of unidentified metabolites. In contrast 
to Trusal and Watiwat (111), O'Brien et al showed that VERO cells 
were not able to metabolise T-2 toxin. 
After the administration of T-2 toxin to swine glucuronides of T-2 
toxin, HT-2 toxin, 3'hydroxy T-2 toxin and 3'hydroxy HT-2 toxin 
appear in their urine and bil~ (113). This would imply that the 
UDP-glucuronyltransferases are also involved in the detoxification 
of T-2 toxin. There are no reports of any in vitro studies 
undertaken to elucidate the role of the UDP glucuronyltransferases 
in the detoxification of T-2 toxin. 
A variety of metabolites are found in the excreta of mice (77), 
chickens (114, 115) and cow (116) after the administration of 
T-2 toxin. The majority of these metabolites found are the 
same as those observed in in vitro experiments, but new ones 
such as 3'-acetoxy-3-hydroxy-HT~2 toxin and 3'-hydroxy-2-hydroxy 
HT-2 toxin are also present. A schematic representation of the 
metabolic pathway, as elucidated by in vivo and in vitro studies, 

























































































































































































































































































































































































































































































































































































































The trichothecenes have a wide spectrum of toxic effects on animals, 
some of which are haemorrhaging, ataxia, diarrhea, reduction in 
numbers of red blood cells, white blood cells and platelets, 
damage to actively dividing cells and suppression of the immuno= 
logical system. They have also been implicated in a number of 
human and animal diseases. 
T-2 toxin is one of the most frequently occurring trichothecenes 
in foodstuffs (117). The acute and chronic toxic effects have 
been well studied in various animal species, indicating considerable 
differences in the toxic effects between species (Section 1.5). 
In order to elucidate the relationship between the detoxification 
of T-2 toxin and its toxicity, the deacylation rate of T-2 toxin 
was compared using rat, cat, monkey and human hepatic microsomes. 
Glucuronides of T-2 toxin and its metabolites have been detected in 
swine bile and urine (113). Since there have been no reports on 
the glucuronidation of T-2 toxin under in vitro conditions, the 
glucuronidation of T-2 toxin was studied using rat and pig 
hepatic microsomes. 
Although neosolaniol monoacetate (NMA) appears to be at least 
as toxic as the well known T-2 toxin (118), little is known about 
its mode of action or toxic properties. It was necessary to isolate 
sufficient amounts of the mycotoxin in order to study the biological 
effects of NMA. 
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Isolation was done from cultures of a South African isolate of 
Fusarium compactum strain MRC 1293 known to produce NMA in 
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culture (119). The biological effects of NMA were studied in the male 
Wistar rats and the effects were compared to those of another 
highly toxic trichothecene, diacetoxyscirpenol. 
CHAPTER 2 
EXPERIMENTAL 
2.1 THE ISOLATION OF NEOSOLANIOL MONOACETATE 
2.1.1 Culture of Fungi 
Yellow maize kernels (400 g) suspended in water (400 mt) were auto= 
claved on 2 consecutive days in 2 liter fruit jars for 1 hour at 
120 kPa. An inoculum of Fusarium compactum strain MRC 1293 was pre= 
prepared by adding distilled water to a lyophilized culture obtained 
from the toxic fungal collection of the South African Medical 
Research Council. The sterilized maize was inoculated and incubated 
for three weeks at 25°C in the dark. Cultures were dried at 45°C, 
ground and stored in airtight containers at 4°C. 
Rice (1 kg) was soaked overnight in distilled water (425 mt) and 100 g 
quantities were placed in 250 mt Erlenmeyer flasks and autoclaved on 
2 consecutive days for 20 minutes at 120 kPa. Inoculums of r. compactum 
strain MRC 1293 and F. sambucinum strain MRC 1903 were prepared, as 
described above. After inoculation, the rice was incubated for 3 weeks 
at 27°C in the dark and stored at 4°C. 
2.1.2 Extraction of Maize Cultures 
Three different procedures were used for the extraction of maize 
cultures: 
(a) Ethyl acetate extraction [Mirocha (120)]: 
The maize culture (50 g) was moistened with water (30% w/v), blended 
with 50 mt ethyl acetate for 2 minutes at full speed in a Sorvall Omni= 
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mixer and filtered through Whatman no. 1 filter paper in a Buchner 
funnel. The ethyl acetate extraction was repeated 3 times, the 
filtrate combined, dried over anhydrous Na2 S0 4 for 3 hours and the 
solvent removed in vacuo at 40°C. The dried extract was partitioned 
between acetonitrile and petroleum ether in a separating funnel and 
the 2 layers were stored separately in Erlenmeyer flasks. The maize 
residue, remaining after ethyl acetate extraction, was extracted 
3 times with 50 mt MeOH:H 2 0 (2:3) by blending and filtration, as 
described. Extracts were combined and stored at 4°C. 
(b) Aqueous methanol extraction: 
The maize culture (50 g) was extracted 3 times with 50 mt MeOH:H 2 0 
(1:1) by blending and filtration, as described above. Extracts were 
combined and stored at 4°C. 
(c) Methanol/chloroform extraction: 
The maize culture (50 g) was extracted 3 times with 50 mt Me0H:CHC1 3 
(2:8) by blending and filtration, a~ described in (a). Extracts 
were combined and stored at 4°C. 
The extracts prepared by the different extraction procedures (a, band 
c) were diluted to 200 mt with the respective solvents and 1:3; 1:15; 
1:63; and 1:255 dilutions were made. The toxicity of 500 µt aliquots 
from each dilution was determined by the brine shrimp assay (Section 
2.2). 
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2.1.3 Extraction of Rice Cultures 
Rice cultures were extracted according to the method of Mirocha (120). 
The cultures (81 g) were extracted three times with 80 mt ethyl 
acetate by blending and filtration, as described in section 2.1.2. 
Extracts were dried over anhydrous Na2 SO~, the ethyl acetate evapo= 
rated in vacuo and the residue partitioned between acetonitrile and 
petroleum ether, as described in section 2.1.2. 
2.1.4 Fractionation of Extracts from Maize Cultures 
The acetonitrile fraction (Section 2.1.2) was evaporated in vacuo and 
the residue (1.1 g), dissolved in a small amount of Me0H:CH2Cl 2 , was 
fractionated on a silica gel (Kieselgel 60:40 g) column (2 x 50 cm) 
using MeOH:CH2Cl 2 (1:19) as eluent. Aliquots (250 µt) of 10 mt 
fractions of the eluate were tested for brine shrimp toxicity (Section 
2.2). The toxic fractions were combined, the solvent evaporated in 
vacuo at 40°C and the residue (0.65 g), redissolved in a small amount 
of MeOH:CHC1 3 and further purified on a Sephadex LH-20 (30 g) column 
(2 x 35 cm) using MeOH:CHC1 3 (1:39) as eluent. Aliquots (100 µt) of 
5 mt fractions of the eluate were tested for toxicity with the brine 
shrimp toxicity assay (Section 2.2). Toxic fractions were combined and 
analysed for the presence of NMA by gas chromatography (GC) (Section 2.3). 
The fractions containing NMA were combined, the solvent removed in 
vacuo at 40°C and the residue (60 mg), redissolved· in a small amount 
of MeOH:CH2Cl2, applied to a silica gel (Kieselgel 60:40 g) column 
(2 x 50 cm) using MeOH:CH2Cl2 (1:19) as eluent. Fractions of the 
eluate (5 mt) were analysed by thin layer chromatography (TLC) using 
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ethyl acetate:CH2Cl2 (3:7) as developing solvent (Section 2.4). 
2.1. 5 Fractionation of Extracts from Rice Cultures 
The acetonitrile fractions obtained from rice cultures of F. sambucinum 
strain MRC 1903 and r. compactum strain MRC 1293 (Section 2.1.3) 
were individually fractionated by silica gel chromatography. The 
solvent was removed in vacuo at 40°C and the residues (0.34 g from 
F. compactum, and 0.72 g from r. sambucinum), redissolved in small 
amounts of MeOH:CH2Cl 2 , were applied to silica gel (Kieselgel 60:40 g) 
columns (2 x 50 cm) using MeOH:CH2Cl2 ' (1:19) as eluent. Fractions 
(10 m~) were collected and analysed by TLC using ethyl acetate: 
CH2Cl 2 (3:7) as developing solvent (Section 2.4). Fractions contai= 
ning NMA were combined and analysed by GC to confirm the presence of 
NMA (Section 2.3). 
The solvent was removed in vacuo at 40°C from the combined fractions 
obtained from the silica gel column fractionation of the F. sambucinum 
extract and the residue (0.32 g), redissolved in a small amount of 
ethyl acetate:CH2Cl 2 , was applied to a silica gel (Kieselgel 60:20 g) 
column (1.5 x 39 cm) using ethyl acetate:CH 2 Cl2 (3:7) as eluent. 
Fractions (10 m~) were collected and analysed by TLC using ethyl 
acetate:CH2 Cll (3:7) as developing solvent (Section 2.4). The 
fractions containing NMA were combined and the solvent removed in 
vacuo at 40°C (residue weight 0.13 g). Final purification of NMA 
was obtained by crystallization using benzene/hexane as solvent. 
Crystals were dried in a dessicator and weighed. 
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2.1.6 Bulk Extraction of Rice Culture 
A bulk extraction of a rice culture of F. sambucinum strain MRC 
1903 (1 kg) was performed. Two batches of 500 g were each extracted 
3 times with 500 me ethyl acetate as described in Section 2.1.2. 
The ethyl acetate extracts were combined, dried over anhydrous Na2S0 4 
and the solvent removed in vacuo at 40°C. The residue was partitioned 
between petroleum ether and acetonitrile, as described in section 
2.1.2, and the solvent was removed from the acetonitrile fraction 
in vacuo. This residue (4.2 g), redissolved in a small amount of 
MeOH:CH2Cl2, was fractionated on a silica gel (Kieselgel 60:300 g) 
column (5 x 500 cm) using Me0H:CH 2 Cl 2 (1:19) as eluent. Fractions 
(50 me) were collected and analysed by TLC (Section 2.4). The 
fractions containing NMA were combined, dried under vacuum and the 
residue (1.64 g), redissolved in ethyl acetate:CH2 Cl 2 , was chromate= 
graphed on a silica gel (Kieselgel 60:100 g) column (3 x 45 cm) using 
ethyl acetate:CH2 Cl 2 (3:7) as eluent. Fractions (10 me) were 
collected and analysed by TLC (Section 2.4). Fractions containing NMA 
were combined and the solvent evaporated in vacuo at 40°C. The 
residue was dissolved in benzene and NMA was crystallized from benzene/ 
hexane. 
2.1. 7 Purity of NMA 
The purity of the NMA crystals was assessed using GC (Section 2.3), 
melting point and mass spectroscopy. A Reichert melting point 
apparatus was used to determine the melting point and the mass spectra= 
scopy was performed at the National Chemical Research Laboratory of the 
CSIR. 
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2.2 BRINE SHRIMP TOXICITY ASSAY 
The brine shrimp toxicity assay was performed by a modification of 
the method of Eppley (121). Brine shrimp (Artemia salina) eggs (0.2 g), 
obtained from a local pet shop, were incubated in 200 me artificial 
sea water (122; Table 2.1 for 24 hours at 28°C). 
TABLE 2.1 Ingredients for artificial sea water 
46.954 g NaCl 
9.962 g MgCl2 
7.834 g Na2SO~ 
2.204 g CaCl2 
1.328 g KCl 
0.384 g NaHC03 
0.192 g KBr 
0.052 g H3 B03 
0.048 g SrC1 2 
0.006 g NaF 
The pH of the artificial sea water was adjusted to 6.7 with 1 M HCl 
and the solution was made up to 2 liters with distilled water. 
Polytop glass vials were washed with soap water, rinsed thoroughly 
with methanol and distilled water and dried at 100°C. Aliquots of 
the fractions to be tested were placed in clean polytop glass vials 
and stored at room temperature (covered with tissue paper) until 
the solvent evaporated completely (ca. 1 day). The brine shrimp 
larvae (ca.30) were drawn up in a plastic disposable syringe in a 
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volume of 1 mt and added to the vials containing the samples to be 
tested. Vials in which pure solvent was evaporated served as 
controls. The vials containing the brine shrimp larvae were incubated 
at 28°C for 48 hours. 
The number of dead brine shrimp larvae were counted under a light 
microscope after 24 and 48 hours. Brine shrimp larvae were 
considered to be dead when no positive forward movement or movement 
of the legs were observed. After the 48 hour count all the shrimps 
were killed by adding acetonitrile and the total number of larvae 
per vial counted. The percentage mortality was then calculated 
for each vial. 
% mortality= number of dead larvae 
total number of larvae 




GC determinations were performed on a Varian model 3700 gas chroma= 
tograph fitted with a capillary column and electron capture detector 
(ECD). The trichothecenes were derivatized by acylation of the 
hydroxyl groups with heptafluorobutyrylimidazole (HFBI) (Figure 2.1) 
to increase the volatility of the compounds as well as to provide 
electron-absorbing halogen atoms enabling detection by ECD. 
A modification of the method of Romer et al (117) was used for the 
derivatization of samples and trichothecene standards. The samples 
were derivatized in 4 mt screw-top vials after the solvent was 
removed under a stream of nitrogen. Toluene:acetonitrile (95:5; 
1 mt) was added to the vials and mixed with 0.1 mt HFBI (Pierce 
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CF.~E-CF-CH-0-R 3 2 2 2 
+ H-i~ 
N 
Fig. 2.1 The derivatization of hydroxyl groups by HFBI. 
Chemical Company). After 1 hour incubation at 60°C, 1 me 0.01 M 
phosphate buffer (pH 6.0) was added, the contents mixed and 
allowed to separate. An aliquot of the organic layer was evapo= 
rated to dryness, dissolved and appropriately diluted in benzene. 
Aliquots of derivatized standards and sample extracts (1 µe) were 
injected using a split injection system onto a bonded SE-30 fused 
silica column (25 m x 0.32 mm i.d.). Helium was used as carrier 
gas and an ECD fitted with a 63 Ni radioactive source was used to 
detect the trichothecenes. Table 2.2 summarizes the exact chromato= 
graphic conditions. 










180°C-250°C at 5°C/min 
Helium; 1.6 me/min 
Nitrogen; 30 me/min 
10:1 
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2.4 THIN LAYER CHROMATOGRAPHIC ANALYSES 
TLC analyses were performed on pre-coated silica TLC plates (Kieselgel 
60, 0.25 mm thickness; Merck (SA)). Samples and standards (12.5 µg 
T-2 toxin, HT-2 toxin, T-2 tetraol and 6.3 µg NMA) were applied in 
spots 2 cm from the bottom of the TLC plate and 0.8 cm apart. TLC 
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plates were developed until the solvent front was 2 cm from the top 
of the plate. The plates were dried at room temperature, sprayed with 
a p-anisaldehyde mixture and heated at 120°C for 10 minutes. The 
p-anisaldehyde mixture consisted of 0.5 g p-anisaldehyde, 85 mt 
methanol, 10 mt glacial acetic acid and 5 mt H2S0 4 • The Rf values 
of the reddish-brown spots in the sample chromatograms were compared 
to those of the trichothecene standards. 
2.5 THE BIOLOGICAL EFFECTS OF DAS AND NMA ON WISTAR RATS 
2.5.1 Experimental Animals 
Male and female Wistar rats (ca. 200 g bodyweight) bred at the 
Research Institute for Nutritional Diseases, MRC, Tygerberg, were 
used. The animals were housed in individual cages and allowed free 
access to rat cubes (Epol Ltd, Cape Town) and tap water. 
2.5.2 Treatment of Animals 
Male and female Wistar rats were used in a preliminary experiment. 
Male rats were divided into four groups with two animals per group. 
Three groups received, respectively, p.a. 3, 1 and 0.2 mg DAS/kg 
bodyweight, while a control group received the solvent dimethyl= 
sulfoxide (DMSO), 3 times a week, i.e. on Mondays, Wednesdays and 
Fridays, over a period of 4 weeks. The female rats received the 
same treatment as the male rats. 
In the main experiment male Wistar rats were divided into two treat= 
ment groups. The rats in the experimental group (30 animals) 
received p.o. 1 mg DAS/kg bodyweight (0.3 mi/200 g bodyweight), 
and the rats in the control group (30 animals) received DMSO (0.3 
mt/200 g bodyweight) three times a week, f?r a period of 5 weeks. 
The experiment conducted with NMA was carried out in an analogous 
way. 
2.5.3 Collection of Blood and Tissue Samples 
During the preliminary experiment with DAS, rats were anaesthetized 
weekly by an i.p. injection of Sagatal (Pentobarbitone: Maybaker 
(S.A.) (Pty) Ltd, Port Elizabeth; 0.85 mi/kg bodyweight). Blood 
samples were collected via cardiac puncture, without opening the 
chest cavity, in Na+EDTA washed plastic disposable syringes and 
transferred to Na+EDTA vacuum tubes (Lab and Scientific, Cape Town). 
In the main experiments with DAS and NMA, five rats from each group 
were sacrificed weekly. The rats were anaesthetized with Sagatal 
and blood samples collected by cardiac puncture. All organs and 
one femur were placed in buffered formalin for pathological exami= 
nation. A bone marrow impression was performed on the remaining 
femur. 
2.5.4 Haematological Parameters 
2.5.4.1 Haematological determinations 
Blood platelets were counted with a Coulter counter Model ZF accor= 
ding to the method supplied with the Coulter Platelet Kit (Coulter 
Diagnostics, Hialea, Florida). Blood was drawn up into a plastic 
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tube (2 mm i.d. x 4 cm) supplied with the platelet kit and allowed 
to stand for approximately 1 hour for the red blood cells to 
sediment, whereafter the platelet rich plasma (33 µt) was diluted 
to 25 mt with Isoton II (Coulter Electronics) and counted. The 
platelet numbers in the dilution was converted to the count in 
blood using the conversion table supplied. The hematocrit was 
determined with a Microhematocrit bench top centrifuge (Hawksley, 
England). 
Red blood and white blood cell counts and other haematological para= 
meters were determined by the department of Haematology, Tygerberg 
Hospital, Tygerberg. The differential white blood cell counts were 
performed by the Pathology Section, RIND, MRC, Tygerberg. 
2.5.4.2 Operation of Coulter Counter 
The Coulter counter operates on a principle whereby particles or 
cells suspended in an electrolyte can be sized and counted by 
passing them through an aperture through which an electrical 
current is flowing. The particles or cells displace an equal 
volume of electrolyte, creating a change in the resistance in the 
path of the electrical current. The resulting current change is 
directly proportional to the size of the particles or cells. By 
drawing a specific volume of sample through the aperture and 
counting the number of voltage changes the number of particles 
or cells in the suspension can be determined. 
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Platelet rich plasma does not only contain platelets, but also red 
blood cells and other cellular debris which are likely to interfere 
with platelet counts. The cellular debris will result in voltage 
changes smaller than those resulting from platelets passing through 
the aperture and red blood cells will lead to voltage changes 
greater than those caused by platelets. The Coulter counter can 
be set to count only voltage impulses larger than a certain thres= 
hold level. 
Two threshold levels can be determined experimentally to allow for 
the counting of platelets. The lower threshold setting will allow 
the counting of voltage changes caused by blood platelets and red 
blood cells, while discarding voltage changes caused by cellular 
debris. The upper threshold level will only count voltage changes 
caused by red blood cells. By subtracting the counts at the upper 
threshold setting from those at the lower threshold setting the counts 
due to platelets can be obtained. Lower and upper threshold levels 
suitable for the counting of rat platelets were determined to be 
5 and 50, respectively. 
To assess the effects of the toxins on blood platelet sizes, counts 
were also obtained at threshold levels of 15 and 25. 
2.5.5 Pathological Examination of Tissues 
The pathological examination of the tissues was performed by the 
pathology section, RIND, MRC, Tygerberg. 
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2.6 IN VITRO STUDIES ON THE METABOLISM OF T-2 TOXIN 
2.6.1 Preparation of Microsomes 
Microsomes were prepared from rat, human, cat, pig and monkey livers. 
In the study on the glucuronidation of T-2 toxin (Section 2.6.4) 
hepatic microsomes were prepared from a pig and phenobarbital induced 
rats. Male Wistar rats received 0.1% phenobarbital in their 
drinking water for five days prior to sacrifice. Induced and un= 
induced rats were starved for 16 hours, sacrificed by decapitation 
and the livers removed. A pig liver was obtained from the Maitland 
abbattoir. A male cat was obtained from a farm near Durbanville 
and the liver was removed under halothane anaesthesia. Delft animal 
Centre, Kuilsriver, supplied a liver biopsy from a female Vervet 
monkey. The monkey was anaesthetized with ketamine hydrochloride 
and exsanguinated. A human liver biopsy was obtained from a kidney 
donor that died from head injuries (Tygerberg Hospital, Tygerberg). 
The livers were homogenized in 3 volumes (v/w) ice-cold 0.25 M 
sucrose in a Sorvall omnimixer. After filtration through 4 layers of 
cheesecloth, the homogenate was further treated in a Dounce homoge= 
nizer using 5 strokes with a "loose" plunger and 8 strokes with a 
"tight" plunger. All procedures were carried out on ice. The 
homogenate was centrifuged at 9000 x g for 20 minutes in a Sorvall 
centrifuge (4°C; SS-34 rotor) and the resulting supernatant was 
centrifuged for 1 hour at 100000 x gin a Beckman 18-70 M ultracentri= 
fuge (4°C; Type 65 rotor). The microsomal pellet was suspended in 
50 mM Tris buffer (pH 7.4) containing 150 mM KCl and stored in 3 mt 
51 
quantities at -80°C. Before use the microsomal preparation was centri= 
fuged at 100000 x g for 1 hour and the pellet resuspended in the buffer 
mentioned in the text. The protein concentration was determined by the 
method of Lowry et al. (123). 
2.6.2 Preparation of T-2 tetraol from T-2 toxin 
T-2 tetraol was prepared from T-2 toxin by the method of Wei (124). 
T-2 toxin (500 mg) was incubated in 25 m~ 1 N ammonia in methanol:water 
(4:1 v/v) for 72 hours at room temperature. The ammonia solution was 
removed in vacuo at 40°C and T-2 tetraol was isolated by chromatography 
on a silica gel (Kieselgel 60: 50g) column (2 x 50 cm) using ethyl 
acetate:acetone:methanol (50:50:1 v/v) as eluent. Fractions containing 
T-2 tetraol, as detected by TLC (Section 2.4), were combined and 
filtered through a Millex-SR 0.5 µm Filter unit (Millipore). On 
evaporation of the solvent in vacuo at room temperature, white 
crystals formed. 210 mg T-2 tetraol was recovered. The purity of T-2 
tetraol was assessed by GC (Section 2.3). 
2.6.3 Microsomal UDP-glucuronyltransferase Activity 
UDP-glucuronyltransferase activity . using phenolpthalein as substrate 
was determined according to the method of Halac and Bonevardi (125) 
Microsomes from phenobarbital induced rats were resuspended in 50 mM 
Tris-HCl buffer (pH 8.0) (Section 2.6.2). The incubation system were 
prepared as follows: (Total volume= 1 mi) 
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16 mM MgC12 
1.6 mM UDP-glucuronic acid (Sigma Chemicals) 
0.671 mM phenolphthalein (Merck) 
50 mM Tris-HCl buffer (pH 8.0) 
1 mg microsomal protein/mt 
The incubation mixture, without UDP-glucuronic acid, was preincubated 
at 37°C for 3 minutes after which UDP-glucuronic acid was added to 
initiate the reaction. After 10 minutes 5 mt of 0.4 M glycine 
buffer (pH 10.5) was added. The mixture was centrifuged at 2000 x g 
for 10 minutes and the concentration of phenolphthalein was determined 
spectrophotometrically on a Beckman spectrophotometer (£ = 12.6 cm 2 / 
µmole at 555 nm). UDP~glucuronyltransferase activity was expressed 
as nmoles phenolphthalein conjugated/min/mg protein. 
2.6.4 The Glucuronidation Assay for T-2 toxin, HT-2 toxin and T-2 
tetraol 
Hepatic microsomes from a pig and phenobarbital induced rats were 
resuspended in 100 mM Tris-HCl buffer (pH 8.0) (Section 2.6.1). The 
microsomal UDP-glucuronyltransferases were activated by the addition 
of Triton X-100 according to the method of Boutin (i25). The 
microsomal suspension was homogenized in a Dounce homogenizer in 
the presence of Triton X-100 (BDH Chemicals) (3.8 µt/10 mg microsomal 
protein) using 4 strokes of a "tight" plunger. The incubation 
mixture was prepared as follows: (Total volume= 1 mt) 
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0.6 mM T-2 tetraol or 0.429 mM T-2 toxin 
16 mM MgC1 2 
4 mM UDP-glucuronic acid 
100 mM Tris-HCl buffer (pH 8.0) 
5 mg microsomal protein/me 
Incubations were carried out in triplicate. The incubation mixture 
without the toxin was preincubated for 3 minutes at 37°C whereafter 
the specific toxin was added to initiate the reaction. Controls 
lacked UDP-glucuronic acid. After an incubation period of 30 minutes 
the reaction was stopped by the addition of 0.2 me 10% trichloroacetic 
acid (TCA), mixed well and placed on ice. The ice-cold reaction 
mixtures were centrifuged in a Sorvall centrifuge (4°C) at 2000 x g 
for 15 minutes and an aliquot (0.6 mt) of the supernatant was 
passed through a Sep-pak C 18 cartridge (Millipore). The cartridge 
was washed 3 times with 2 mt water to remove salts present in the 
supernatant while the toxins were eluted with 2 washes of 2 mt 
methanol and collected in 4 mt screw-top vials. 
The eluates were dried under a stream of nitrogen and the residues 
were derivatized and analysed by GC (Section 2.3). The concentrations 
of the toxins present in the eluates were determined from standard 
curves compiled on each day, using 1 µt injections of the following 




250, 500, 750, 1000 ng/mt 
75, 150, 225, 300 ng/mt 
50, 100, 150, 200 ng/mt. 
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Illustrations of the standard curves are presented in figures 2.2, 
2.3 and 2.4. 
2.6.5 Deacylation Assay for T-2 toxin 
The microsomes prepared from rat, human, cat and monkey livers 
were resuspended in 50 mM Tris-HCl buffer containing 150 mM KCl 
(pH mentioned in the text) (Section 2.6.2). 
The standard incubation mixture consisted of the following in a 
total volume of 1 me: 
T-2 toxin 
50 mM Tris-HCl buffer containing 150 mM KCl 
microsomes. 
After preincubation of the microsomes for 3 minutes at the required 
temperature T-2 toxin was added to initiate the reaction. The 
reaction was stopped by the addition of 0.2 me 10% TCA and the 
substrate and products were isolated using a Sep-pak C 18 cartridge, 
as described in Section 2.6.4. Gas chromatography was used to 
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monitor the conversion of T-2 toxin to HT-2 toxin (Section 2.3 and 2.4). 
2.6.5.1 Effect of temperature 
The effect of temperature on the deacylation reaction with rat 
microsomes (1 mg microsomal protein/me) and T-2 toxin (0.5 mM) 
was determined by duplicate determinations at pH 7.4 and at 25, 30, 
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Fig. 2.4 Standard curve for the quantification of T-2 tetraol by GC. 
2.6.5.2 Effect of pH 
The effect of pH on the deacylation reaction was determined by 
performing assays at pH 7. 0, 7. 4, 8. 0 .and 8. 5 for rat microsomes 
and at pH 7.0, 7.4, 8.0, 8.5 and 9.0 for microsomes from cat, 
monkey and human liver at 37°C as in table 2.3. 
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As a control, T-2 toxin (0.56 mM) was incubated without microsomes 
at 37°C for 30 minutes with buffer at pH 7.4, 8.0, 8.5 and 9.0. 
2.6.5.3 Time course study 
Microsomes from the different sources were incubated (in duplicate) 
at 37°C and pH 7.4 for different time intervals as shown in table 
2.4. 
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TABLE 2.4 ASSAY CONDITIONS FOR THE TIME COURSE STUDY 
Source Microsomal protein T-2 toxin Incubation 
concentration (mg/mt) concentration (mM) times (min) 
rat 1.0 0.50 5, 10, 15 
human 1.0 0.56 5, 10, 20 
' cat 2.0 0.56 15, 30, 45, 60 
monkey 1.0 0.56 10, 20, 40 
2.6.5.4 Kinetic studies 
In order to determine the kinetic constants of the deacylation reaction 
the initial velocities of the deacylation reaction were determined 
at pH 7.4 and 37°C, using the conditions in table 2.5. 
TABLE 2.5 ASSAY CONDITIONS FOR THE KINETIC STUDIES 
Source Microsomal protein Incubation T-2 toxin concentra= 
concentration (mg/mt) time (min) tions (mM) 
rat 1 10 0.14, 0.28, 0.42, 
0.56, 0.70 
human 1 5 0.27, 0.54, 0.8, 1.07 
' 
1.34 
cat 2 30 0.27, 0.54, 0.8, 1.07, 
1.34 
monkey 1 15 0.27, 0.54, 0.8, 1.07, 
1.34 
2.7 STATISTICAL ANALYSIS 
All data are represented as means~ standard deviations. 
Multiple comparisons were performed on the haematological para= 
meters obtained from the in vivo experiments (Section 4.5) using 
Tukey's (140) and Gabriel's (141) tests. P <0,05 was considered to be 
significant. The statistical analyses were performed by the Insti= 
tute of Biostatistics, MRC, Tygerberg. The Student's T-test was used 
to determine statistically significant differences in in vitro 
results. 
2.8 MATERIALS 
All reagents used were of analytical grade and obtained from Merck 
(SA). 
HT-2 toxin standard were obta~ned from Makar Chemicals, Israel. 
DAS and T-2 toxin were previously isolated in our laboratory. 
NMA standards were obtained as gifts from Dr K Ishii, Japan, and 




3.1 ISOLATION OF NMA FROM MAIZE CULTURES OF FUSARIUM COMPACTUM 
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Cultures of F. compactum strain MRC 1293 grown on maize were extracted 
with different solvent mixtures (Fig. 3.1) (Section 2.1.2) and dilutions 
of the extracts were subjected to the brine shrimp toxicity assay 
(Section 2.2), as it has previously been used to isolate tricho= 
thecenes (121). The toxicities of the extracts at comparable 
concentrations are represented in Figures 3.2 and 3.3. 
The ethyl acetate, MeOH:H20 (1:1) and MeOH:CHC1 3 (2:8) extracts 
were toxic to brine shrimp larvae, and both the undiluted and 1:3 
dilutions resulted in a 100% mortality. The 1:15 dilution of the 
ethyl acetate extract was slightly more toxic than the corresponding 
dilutions of Me0H:H2 0 (1:1) and MeOH:CHC1 3 (2:8) extracts, while no 
toxicity was observed with higher dilutions. The residue remaining 
after ethyl acetate extraction was re-extracted with Me0H:H 2 0 (2:3) 
to determine whether ethyl acetate extraction removed all toxic 
material. Toxicity could however still be recovered from the maize 
residue. 
After partitioning of the dried ethyl acetate extract between petro= 
leum ether and acetonitrile (Section 2.1.2), the bulk of the toxicity 
was recovered in the acetonitrile phase, while only a minute amount 
of toxicity was present in the petroleum ether phase (Fig. 3.3). 
Twenty-one percent (w/w) of the ethyl acetate residue was recovered 






Extract with ethyl acetate 
Maize Ethyl acetate extract 
Extract with 
MeOH:H20 (2:3) 





MeOH: H2 0 ( 1: 1) 
MeOH:H 2 0 (1:1) extract 
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l Extract with MeOH:CHC1 3 (2:8) 
CHC1 3 :MeOH (2:8) extract 
remove solvent and 
partition residue between 
petroleum ether and 
acetonitrile 
acetonitrile 
Fig. 3.1 The extraction of maize cultures with different solvent 



















>- - :! 
50
 






































































































































































































































































































































































































































































































































Silica gel and Sephadex LH-20 column chromatography were used for 
the further purification of the acetonitrile extract (Section 
2.1.4). Fractions from the silica column were tested for brine 
shrimp toxicity (Section 2.2). Toxic fractions (15-28, Fig. 3.4) 
were combined and subjected to further fractionation by Sephadex 
LH-20 column chromatography (Section 2.1.4). Two major toxic areas 
were observed (Fig. 3.5). Fractions 2 to 7 (A), 8 to 14 (B) and 
20 to 30 (C) were combined, and an aliquot of each of A, Band C 
was subjected to GC analysis (Section 2.3). The results indicated 
the presence of NMA in fraction A. 
Fraction A was further fractionated by silica gel column chromatography 
(Section 2.1.4) and the eluate subjected to TLC analysis (Section 2.4). 
Fractions 4 to 8 contained a compound(s) that had the same Rf value 
(0.17) as the NMA standard. Fractions 4 and 5 (I) and 6, 7 and 8 
(II) were combined, respectively, and analysed by GC (Section 2.3). 
NMA was present in fraction I (Fig. 3.6), but the chromatogram 
indicated the presence of many other contaminating compounds. 
3.2 ISOLATION OF NMA FROM RICE CULTURES OFF. COMPACTUM AND 
F. SAMBUCINUM 
Rice cultures off· compactum strain MRC 1293 and f· sambucinum strain 
MRC 1903 were extracted with ethyl acetate and the extract was 
partitioned between acetonitrile and petroleum ether (Section 2.1.3). 
The acetonitrile extracts were fractionated by silica gel column 
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GC analysis of fraction I (Section 3.1). 
analysis (Section 2.4) and those fractions containing NMA (Rf= 0.17) 
were combined and subjected to GC analysis (Fig. 3.7). The amount 
of NMA produced by F. sambucinum was more than that produced by F. 
compactum. The F. sambucinum extract was further purified on 
another silica column (Section 2.1.5). TLC analysis was performed 
on the fractions and those containing NMA were combined. 
Pure NMA (29 mg) was recovered from this material by crystallization 
from benzene:hexane (Section 2.1.5). This represents a yield of 
358 mg/kg rice culture. A large scale extraction of the rice 
culture (Section 2.1.6) yielded only 50 mg/kg. The melting point 
of the crystalline NMA was found to be 190-192°C and GC analysis 
revealed only one peak at the same retention time as the NMA standard. 
The mass spectrum of the crystalline NMA is given in Figure 3.8. 
3.3 BIOLOGICAL EFFECT OF DAS AND NMA IN RATS 
3.3.1 Preliminary Experiments 
Male and female Wistar rats received p.o. 3.0, 1.0 and 0.2 mg DAS/kg 
bodyweight three times a week over a 4 week period (Section 2.5.2) 
and blood samples were collected as described in section 2.5.3. 
The results indicated that the dosage level of 3.0 mg DAS/kg could 
not be used for chronic studies as the rats died within two weeks 
after the commencement of the experiment. The male and female rats 
receiving 1.0 and 0.2 mg DAS/kg survived the 4 week experimental 
period. Blood platelet levels were not influenced at any of the 
dosage levels. The only change observed in haematological parameters 
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Fig. 3.7 
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GC analysis of the combined column fractions containing 
NMA, as determined by TLC, resulting from the fractionation 
of the acetonitrile extract of rice on a silica column 





























































































































































































































































































































































was a decrease in the hematocrit (% red blood cells in blood) of rats 
treated at both levels of DAS. Treatment with DAS resulted in a 
reduced growth rate, when compared with the controls. The changes 
observed in the hematocrit and growth rate were more pronounced 
in the rats receiving 1.0 mg/kg than in those receiving 0.2 mg/kg. 
Male rats were more susceptible to DAS than females at a dosage 
level of 1.0 mg/kg, while at a level of 0.2 mg/kg there was no 
difference between males and females. Further studies were performed 
with male rats at a dose of 1.0 mg DAS/kg. 
3.3.2 The Effect of DAS and NMA on Male Wistar Rats 
Male Wistar rats received 1 mg DAS/kg bodyweight and 1 mg NMA/kg 
bodyweight, respectively, p.o. three times a week over a six week 
period (Section 2.5.2). The changes in haematological parameters 
and pathological changes in the organs were examined. 
Treatment of rats with DAS and NMA slightly reduced the increase in 
bodyweight in rats receiving the toxins, when ccxnpared with that in 
the control animals (Fig. 3.9). The coats of rats treated with the 
toxins were not as shiny and smooth as those of the controls. The 
administration of DAS resulted in two cases of severe diarrhea, while 
no case of diarrhea occurred in any of the rats treated with NMA 
or in the controls. 
3.3.2.1 The effect of DAS and NMA on the haematological parameters 
of rats 
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The effect of DAS (a) and NMA (b) on the bodyweight of rats. 
Rats were treated as described in Section 2.5.2 (~- controls; 
----- treated). 
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the experimental period (Fig. 3.10). DAS clearly had no significant 
effect on the platelet levels when compared with that in control 
animals. Although it appears as if treatment with NMA resulted in 
a decrease in platelet levels, statistical analysis (Section 2.7) 
indicated that this decrease was not significant. 
The only significant effect on blood platelets was a change in size 
after treatment with either of the toxins. (Fig. 3.11 and 3.12). 
Absolute sizes of platelets were not measured but rather the relative 
numbers of platelets counted in the Coulter counter at different 
threshold settings (Section 2.5.4.2). Treatment with both DAS and 
NMA resulted in a significant increase in the number of larger 
platelets. This change was already observed one week after the 
commencement of the experiment and lasted the whole experimental 
period. 
DAS and NMA had no significant effect on the total white blood cell 
levels in rats (Fig. 3.13) or on the lymphocyte, neutrophil or 
monocyte counts (Fig. 3.14, 3.15, 3.16). While it appeared as if 
there was a reduction in the eosinophil count from day 21 onwards 
this decrease was not statistically significant (Fig. 3.17). 
Treatment of rats with DAS and NMA resulted in a significant reduc= 
tion in the red blood cell counts when compared with controls (Fig. 
3.18). The red blood cell counts of the control rats showed a 
tendency to increase as the rats aged. The same tendency was 
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Fig. 3.10 The effect of DAS (a) and NMA (b) on the platelet levels 
of rats. Rats were treated as described in Section 2.5.2 
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Fig. 3.11 The effect of DAS on the size distribution of platelets. 
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Fig. 3.13 The effect of DAS (a) and NMA (b) on the total white blood 
cell counts. Rats were treated as described in Section 2.5.2 
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Fig. 3.14 The effect of DAS (a) and NMA (b) on the lymphocyte counts. 
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Fig. 3.15 The effect of DAS (a) and NMA (b) on the neutrophil 
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Fig. 3.16 The effect of DAS (a) and NMA (b) on the monocyte counts. 
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The effect of DAS (a) and NMA (b) on the eosinophil counts. 
Rats were treated as described in Section 2.5.2 (~- control; 
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Fig. 3.18 The effect of DAS (a) and NMA (b) on the red blood cell 
counts.~ indicates statistically significant differences 
(P <0.05). Rats were treated as described in Section 2.5.2. 
(-- control; treated). 
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than that of the control groups. 
The amount of haemoglobin in the red blood cells and their mean 
cell volumes (Fig. 2.19 and Fig. 3.20) were not affected by 
treatment with DAS and NMA. In contrast,treatment with DAS and NMA 
resulted in a decrease in the amount of haemoglobin present in blood 
(Fig. 3.21). The haemoglobin content of rat blood increased as the 
rats aged, but the rats treated with NMA and DAS had significantly 
lower haemoglobin contents than controls. The hematocrit of the 
rats increased with age in the controls as well as in those rats 
treated with the toxins (Fig. 3.22). The hematocrit was however 
significantly lower in those animals treated with the toxins. 
3.3.2.2 Pathological changes 
The animals treated with DAS and NMA generally presented with mild 
pathological changes. Affected spleen tissue in rats treated with 
DAS showed moderate or mild atrophy. Most significant were the 
depletion of the lymphoid population of periarteriolar sheaths and 
follicles, lymphocyte depletion and reticular cell predominance in 
the red pulp. 
Treatment with DAS resulted in lymphocyte disappearance and an 
increasing number of granulocytes in the thymic cortex. No 
changes were observed in the thymus of rats treated with NMA. 
Bone marrow and lymphatic node atrophy was observed in rats treated 
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Fig. 3.19 The effect of DAS (a) and NMA (b) on the mean cell 
haemoglobin of red blood cells. Rats were treated as 
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Fig. 3.20 The effect of DAS (a) and NMA (b) on the mean cell 
volume. Rats were treated as described in Section 2.5.2. 
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Fig. 3.21 The effect of DAS (a) and NMA (b) on the total haemoglobin 
content of blood. ¥- indicates statistically significant 
differences (P <0.05). Rats were treated as described 
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Fig. 3.22 The effect of DAS (a) and NMA (b) on the hernatocrit. 
Statistical differences are indicated by• (P <0.05). 
Rats were treated as described in Section 2.5.2 (~- control; 
-----treated). 
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of myeloid cells and a depletion of megakaryocytes~ Similar 
changes were observed in rats treated with NMA. 
The regularity of pathological changes connected with DAS treatment 
were noted from day 14 and persisted up to day 28. On day 35 the 
bone marrow, thymus and lymphatic nodes showed signs of recovery. 
Similar observations were made in rats treated with NMA. 
3.4 GLUCURONIDATION OF T-2 TOXIN AND SOME OF ITS METABOLITES 
3.4.1 Microsomal UDP-glucuronyltransferase Activity 
Liver microsomal UDP-glucuronyltransferase activity of phenobarbital 
induced rats was determined according to the method of Halac and 
Bonevardi (125, Section 2.7.2) using phenolphthalein as substrate. 
The specific activity of the microsomal preparation was found to 
be 11.2 nmoles phenolphthalein conjugated/min/mg protein. 
3.4.2 The Conjugation of T-2 Toxin and its Metabolites 
The potential glucuronidation of T-2 toxin, HT-2 toxin and T-2 
tetraol was studied using activated hepatic microsomes from a 
pig and phenobarbital induced rats (Section 3.6.4). The reaction 
was followed by determining the amount of unconjugated substrate 
at different time intervals by GC. 
As T-2 toxin is converted to HT-2 toxin in the presence of microsomes 
(Section 3.5) the potential conjugation of both T-2 toxin and HT-2 
toxin could be followed when only T-2 toxin was used as substrate. 
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The microsomal conversion of T-2 toxin to HT-2 toxin was near to 
completion after 30 minutes of incubation with pig and rat micro= 
somes, both in the absence and presence of UDP-glucuronic acid. 
In the presence of UDP-glucuronic acid 0.425 ! 0.009 µmoles HT-2 
toxin was formed when T-2 toxin was incubated with rat microsomes, 
while in the absence of UDP-glucuronic acid 0.452 + 0.003 µmoles 
HT-2 toxin was formed. When T-2 toxin was incubated with pig 
microsomes and UDP~glucuronic acid 0.417 ! 0.109 µmoles HT-2 
toxin was formed, while in the absence of UDP-glucuronic acid 
0.399 ! 0.049 µmoles HT-2 toxin was formed. No remaining T-2 
toxin was detectable in any of the incubations. There were no 
statistical differences (Section 2.7) between incubations with or 
without UDP-glucuronic acid. 
When T-2 tetraol was incubated with rat microsomes (Section 2.6.4) 
0.594 + 0.020 µmoles T-2 tetraol and 0.578 + 0.016 µmoles T-2 
tetraol remained after incubations without and with UDP-glucuronic 
acid, respectively. There was no significant change in the T-2 
tetraol concentration resulting from the presence of UDP-glucuronic 
acid. 
3.5 DEACYLATION OF T-2 TOXIN 
The deacylation of T-2 toxin to HT-2 toxin was studied using rat, 
human, cat and monkey hepatic microsomes (Section 2.6.5). The effect 
of temperature and pH on the deacylation reaction was also investig= 
gated (Sections 2.6.5.1 and 2.6.5.2). 
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3.5.1 Effect of Temperature 
The deacylation reaction catalysed by rat liver microsomes was 
shown to be dependent on temperature with an optimum at 37°C 
(Fig. 3.23). Thereafter all kinetic studies were performed at 
this temperature. 
3.5.2 Effect of pH 
The pH of the deacylation reaction differed markedly between the 
various animal species (Fig. 3.24). Rat and human microsomes 
showed a pH optimum at pH 7.4 and 8.0, respectively, while the rate 
decreased at higher pH values. The pH optimum for cat microsomes 
was observed at pH 8.0 to 9.0 while that for monkey microsomes 
was observed at pH 8.5. The deacylation rate for these two 
species did not decrease considerably at higher pH values. Non-
enzymatic deacylation was found to occur at higher pH values 
in the absence of microsomes. 
3.5.3 Kinetic Studies 
In order to study the kinetics of the deacylation of T-2 toxin it 
was necessary to determine the initial reaction rates. Time 
course studies were therefore performed to determine the time 
interval that a linear reaction rate was maintained (Section 
2.6.5.3). The deacylation rate was linear with rat and human 
microsomes over 15 and 20 minutes, respectively (Fig. 3.25). As 
the deacylation with human microsomes was much faster than with 
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Fig. 3 . 23 The effect of temperature on the deacylation of T- 2 toxin 
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Fig. 3.25 Time course studies of the deacylation of T-2 toxin by 
rat, human, cat and monkey hepatic microsomes (Section 2.6.5.3). 
kinetic parameters were stopped after 5 and 10 minutes when 
using human and rat microsomes, respectively. Because the 
deacylation rate was lower with cat and monkey microsomes the 
time course studies were performed over longer time intervals. 
The deacylation with cat microsomes was linear for 30 minutes 
while that for monkey microsomes was linear for 20 minutes. 
Incubation times of 30 and 15 minutes were used in the kinetic 
studies with cat and monkey microsomes, respectively. 
Kinetic studies as different substrate concentrations (Section 
2.6.5.4) indicated that the deacylation rate was the highest 
with human and rat microsomes while with cat and monkey microsomes 
the deacylation rates appeared to be similar but about a hundred 
times lower than the rate with human microsomes (Fig. 3.26). 
When the data obtained with cat and monkey microsomes were plotted 
on an expanded scale (Fig. 3.27) it was clear that the plots 
followed a sigmoidal shape. 
The rate constants for the reaction with rat and human microsomes 
were determined using the Eadie-Hofstee plot (Fig. 3.28). For 
the rat microsomes the Km and Vmax were found to be 0.51 mM and 29.2 
nmol HT-2 toxin/min/mg protein, respectively. With the human 
microsomes the Km and Vmax were found to be 1.4 mM and 95.6 nmol 
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Fig. 3.26 The effect of T-2 toxin concentration on the deacylation 
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4.1 ISOLATION OF NMA 
It was necessary to isolate sufficient amounts of neosolaniol mono= 
acetate (NMA) to perform in vivo studies with experimental animals. 
Two groups independantly isolated NMA from liquid cultures of two 
different Fusarium species. Lansden et al (127) isolated NMA from 
cultures of F. tricinctum strain NRRL 23377, identified as F. chlamydo= 
sporum strain MRC 2486 by Nelson et al (15), while Ishii et al (118) 
isolated the toxin from cultures of F. roseum strain V-18, identi= 
fied as F. sambucinum strain MRC 1903 by Nelson et al (15). It is 
well known that the Fusaria produce larger quantities of toxins on 
solid substrates than in liquid media (8). Therefore an attempt 
was made to isolate NMA from maize cultures of I· compactum strain 
MRC 1293, even though the isolation of toxins from liquid cultures 
is generally easier due to less interfering substances. The brine 
shrimp toxicity assay, a biological monitoring system previously 
used for the isolation of several trichothecenes (121), was 
employed in this study. 
Of the three solvent systems tested for extraction, ethyl acetate 
proved to be more suitable for recovering toxicity (Fig. 3.1). 
Although MeOH/H20 and MeOH/CHC1 3 extracted only slightly less 
toxicity these solvent systems are likely to extract far more 
polar substances that can interfere in the purification of NMA. 
The liquid-liquid partitioning of the ethyl acetate residue 
between acetonitrile and petroleum ether resulted in a five 
fold purification. Twenty percent of the ethyl acetate residue 
containing the bulk of the toxicity (Fig. 3.3) was recovered in 
the acetonitrile phase. The low toxicity detected in the petro= 
leum ether phase was most probably due to the presence of fatty 
acids and other fat soluble compounds, which are also toxic to 
brine shrimps (128). 
Column chromatography is frequently used for the fractionation 
of toxic extracts (118, 129). Fractionations using silica gel 
and Sephadex LH-20 column chromatography in this study (Section 
3.1) were unsuccessful in purifying NMA from maize extracts due 
to the co-elution of interfering substances with the toxin in 
both systems. A report by Vesonder et al (130) stated that rice 
cultures of F. graminearum proved to be more suitable than maize 
cultures for isolating deoxynivalenol. An attempt was therefore 
made to isolate NMA from rice cultures of I· compactum. Rice 
cultures of F. sambucinum strain MRC 1903, one of the first 
strains from which NMA was isolated, were also included. 
TLC could be used to screen the column eluates during the fractio= 
nation of the acetonitrile extracts from rice cultures, whereas 
with the maize extracts too many interfering substances were 
present. The eluates from the first column fractionations of 
rice cultures of F. sambucinum (Fig. 3.7) and I· compactum 
contained less interfering substances than the eluate from the 
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third column fractionation of the extract from the maize culture 
of F. compactum (Fig. 3.6). This agrees with the observations made 
by Versonder et al (130). GC analysis revealed that F. sambucinum 
strain MRC 1903 produced more NMA than K· compactum strain MRC 
1293, therefore the former was used for the large scale isolation 
of NMA. 
102 
Based on the small scale isolation of NMA, the yield from a bulk 
culture of F. sambucinum was 7 times less than expected (Section 3.2). 
Several factors could have contributed to the lower yield: (1) The 
culture conditicns during bulk cultivation were not optimal for 
toxin production (2) The inoculum used was not as viable compared 
to that used during the small scale cultivation (3) The extraction 
procedure was not as efficient with larger samples as with 
smaller samples. 
The isolated NMA was shown to be pure by using a number of physico-
chemical techniques. The melting point of the isolated NMA 
(190-192°C) compared well with published values (190-190.5°C (127) 
and 189-190°C (118)) while GC analysis showed a single peak 
eluting at the same position as a NMA standard. Mass spectral 
analysis showed the characteristic fragment peaks observed in 
published spectra (Fig. 3.8). No molecular ion was however 
detected. 
4.2 BIOLOGICAL EFFECTS OF DAS AND NMA 
The LDso values of NMA (0.789 mg/kg) and T-2 toxin (1.84 mg/kg) 
in day old cockerels suggest that NMA is more toxic than T-2 
toxin (127), while DAS (LD 50 = 7.3 mg/kg) is less toxic to rats 
than T-2 toxin (LD 50 = 5.2 mg/kg) (18). It is important that in 
chronic studies with toxins a dose should be selected that can be 
administered repeatedly without being lethal to the experimental 
animals, while still being high enough to induce detectable changes 
in the animals. Preliminary studies indicated that a dose of 1 mg 
DAS/kg bodyweight 3 times a week would be suitable for chronic 
studies in rats. NMA was administered at the same dose so as 
to compare the chronic effects of these two toxins. 
Of all the haematological parameters examined the red blood cell 
counts appeared to be the most sensitive to DAS and NMA. Since 
the mean cell volume and the mean cell haemoglobin did not 
change during the experimental period it would seem that the red 
blood cells themselves were not affected by the action of the 
103 
toxins. DAS and NMA treatment resulted in a statistically significant 
cant decrease in the hematocrit and haemoglobin content, thus 
agreeing with the decrease in the red blood cell count. This can 
be expected as the hematocrit and haemoglobin content of blood 
are directly related to the red blood cell count. Stahelin (21) 
obtained similar results in a rat experiment performed with DAS. 
It would appear that a reduction of red blood cells is a general 
characteristic of the action of the trichothecenes as T-2 toxin 
also causes decreases in red blood cell counts in cats and monkeys 
(10, 39). 
Blood platelet levels decrease in dogs treated with DAS (21) and 
in rats there is a very mild decrease in the white blood cell 
counts (21). As with DAS, T-2 toxin treatment also resulted in 
a decrease in platelet and white blood cell counts in various 
animal species (31, 36, 39, 60). In the present study the rats 
treated with DAS and NMA did not show any significant reduction 
in the platelet or white blood cell counts. Treatment with NMA 
did however seem to lower the platelet levels compared to 
controls (Fig. 3.10) but the difference was not statistically 
significant. Pathological examination of the bone marrow revealed 
a decrease in the number of megakaryocytes, the cells from which 
platelets are formed. A decrease in the platelet counts was there= 
fore expected. 
An increase in platelet size was observed with both the NMA and 
DAS treatments. Circulating platelets are not homogenous with 
regard to size, density and function and these differences are 
related to age (131). Younger platelets are larger than platelets 
that have been in the circulation for a few days. The results 
obtained from treatment with NMA and DAS seem to indicate an 
increased proportion of young platelets in the circulation possibly 
caused by the destruction of circulating blood platelets. However 
no reduction in the platelet counts was observed which could be 
ascribed to the short period of exposure. 
The atrophy of actively dividing cells of the bone marrow, thymus, 
spleen and lymph nodes observed after treatment with DAS and NMA 
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is characteristic of lesions induced by trichothecenes (27-29, 
34, 40, 52, 67, 68). DAS caused the greatest changes in the 
cortex of the thymus similar to the observations with T-2 toxin 
in mice (30). After five weeks the bone marrow, thymus and lymph 
nodes showed signs of recovery. Similar recoveries were observed 
in chickens that received dietary T-2 toxin (69). It is possible 
that chronic exposure to the toxins could have increased the capa= 
bility of the detoxification pathways. 
4.3 GLUCURONIDATION OF T-2 TOXIN AND SOME OF ITS METABOLITES 
UDP-glucuronyltransferases catalyse the transfer of glucuronic 
acid from UDP-glucuronic acid to hydrophobic, fat soluble mole= 
cules thereby increasing their polarity and water solubility 
to fascilitate their excretion (132, 133). As the glucuroni= 
dation of T-2 toxin or its metabolites could play an important 
role in the detoxification of this toxin, in vitro conjugation 
studies were undertaken. 
In freshly prepared microsomes the UDP-glucuronyltransferases 
exist in a latent state (134) and can be activated by detergents, 
which are thought to involve the partial solubilization of the 
enzyme (135, 136). In this study the microsomes were treated 
with Triton X-100 (Section 2.7.3). 
GC was used to monitor enzymatic conjugation by determining the 
residual substrate concentrations after incubating the toxin 
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with microsomes in the presence of UDP-glucuronic acid. Prior 
to GC analysis interfering substances were removed from the 
reaction mixture. Microsomes were precipitated with TCA and 
removed by centrifugation. After application of the supernatant 
to a C18 Sep-Pak cartridge the polar constituents, UDP-glucuronic 
acid, glucuronides (if they were formed) and salts were eluted 
from the cartridge with water. The toxins, retained on the 
cartridge, were then eluted with methanol and quantified by GC. 
The recovery of the toxins from the cartridge was approximately 
98%. 
No significant glucuronidation could be detected using T-2 toxin 
or T-2 tetraol as substrates for either pig or rat hepatic micro= 
somal transferases. The presence of additional hydroxyl groups 
on the trichothecene molecules, as in T-2 tetraol, did not seem 
to play a role in the potential conjugation reaction. The fact 
that glucuronidation of these trichothecenes was not observed with 
rat microsomes could not be due to a lack of UDP-glucuronyltrans= 
ferase activity of these microsomes, as active conjugation of 
phenolphthalein was catalysed by this microsomal preparation 
(Section 3.3.1). Although T-2 toxin and HT-2 toxin appear not 
to be glucuronidated under the in vitro conditions employed 
(Section 3.3.2), glucuronides of T-2 toxin, HT-2 toxin, 3'hydroxy 
T-2 toxin and 3'hydroxy HT-2 toxin have recently been detected 
in the bile and urine of pigs treated with T-2 toxin (113). It 
would thus appear as if the in vitro methods employed for the 
glucuronidation of T-2 toxin and its metabolites were not suitable 
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and require further investigation. 
4.4 DEACYLATION OF T-2 TOXIN 
T-2 toxin is one of the most toxic trichothecenes but it is 
known that species differ considerably in their susceptibility 
to T-2 toxin toxicity. LD 50 values for T-2 toxin vary by more 
than 10 fold - from 5.2 mg/kg in the rat to <0.5 mg/kg in the 
cat (18). 
T-2 toxin is converted to HT-2 toxin by a microsomal esterase (137) 
as part of the detoxification pathway (Section 1.5.2). This 
deacylation rate was studied in microsomes prepared from rat, human, 
cat and monkey to obtain further information regarding the 
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species d~fferences in detoxification. Human hepatic microsomes were 
included in this study as T-2 toxin has been associated with the 
human disease ATA (9). 
Kinetic studies with microsomes to determine the rate of deacy= 
lation were performed at pH 7.4, as non-enzymatic deacylation 
was found to occur at higher pH values (Section 3.5.2). However, 
the pH optima for the esterase in cat, monkey and human microsomes 
were found to be between pH 8 and 9 (Section 3.5.2). These 
findings would imply that under in vivo conditions (pH 7.4) the 
deacylation of T-2 toxin will not occur under optimal conditions. 
The Km obtained for the deacylation reaction with rat microsomes 
(0.51 mM) is of the same order as the Km (0.27 mM) obtained by 
Ohta et al (106). The Km of human (1.4 mM) is 3 times higher than 
that for rat microsomes which implies that the affinity of the 
human microsomal esterase for T-2 toxin is lower than that of the 
rat esterase. The sigmoidal curves obtained with cat and monkey 
microsomes (Fig. 3.27) are characteristic of allosteric enzymes 
which exhibit positive co-operativity. Main (138) observed that 
certain mammalian liver and serum esterases show this allosteric 
behaviour with butyrylthiocholine as substrate. He postulates that 
the enzyme has two binding sites for the substrate, an allosteric 
and an active site. At low substrate concentrations with little 
binding of substrate to the allosteric site, the affinity of the 
active site for the substrate is low. As the substrate concen= 
tration increases the substrate will bind to the allosteric site 
which will in turn increase the affinity of the active site for 
the substrate, thereby increasing the rate of the reaction. It is 
pa,sible that the results obtained with cat and monkey microsomes 
can also be explained by this kind of reaction mechanism. 
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The high deacylation rate observed with rat and the low rate observed 
with cat and monkey microsomes correlated with the low sensitivity 
of rats and the high sensitivity of cats and monkeys to T-2 toxin toxi= 
city. These findings suggested that the conversion of T-2 
toxin to HT-2 toxin could be the important step in the detoxification 
of T-2 toxin in rats, cats and monkeys and that T-2 toxin is likely 
to be the toxic entity in these species. In human microsomes the 
deacylation rate was very high when compared to the other species 
investigated, suggesting that human might not be as sensitive to 
the action of T-2 toxin. This is, however, not the case as T-2 
toxin appears to be highly toxic to humans (9). If the toxic 
mechanism of action of T-2 toxin is the same in cats, humans and 
monkeys, it would imply that the deacylation of T-2 toxin is not 
an important detoxification step in humans. It is important 
to remember that under in vivo conditions, the concentrations 
of T-2 toxin in the livers of animals might never reach the 
higher levels reported in Fig. 3.26. To predict the differences 
in deacylation rate between the different species from the data 
in Fig. 3.26 comparisons should be made at those concentrations 
of T-2 toxin which occur in the liver after p.o. administration 
of similar doses to different species. 
Care should be taken in drawing conclusions from these results as 
the deacylation rate determinations were performed on microsomes 
obtained from only one monkey, cat and human. As considerable 
intraspecies variation can occur in esterase activity (139), the 
results reported here may not necessarily be a true reflection of 
the activities in these species. The human liver was exposed to 
dexamethasone and diphenylhydantoin during the two days prior to 
death~ These two drugs are known to be inducers of microsomal 
enzymes and might have contributed to the high deacylation rate. 
However a period of 1 to 2 days is probably too short to result 
in a detectable induction of the esterase activity. 
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If the deacylation rates observed in this study truly measure 
the rate of detoxification in each species the results would suggest 
that a metabolite of T-2 toxin is responsible for the toxic effects 
in humans. A study of the in vivo metabolism of T-2 toxin in 
chickens indicates that the conversion of T-2 toxin to HT-2 
toxin is the main step in the detoxification (114). In a 
lactating cow, however, it seems that the hydroxylation of T-2 toxin 
to 3'hydroxy T-2 toxin is the major detoxification step (116). The 
formation of 3' hydroxy T-2 toxin was not studied in the present 
investigation so it is not known whether the formation of 3' 
hydroxy T-2 toxin occurs at a rate similar to or faster than 
the formation of HT-2 toxin in humans. It is possible that HT-2 
toxin and/or 3'hydroxy T-2 toxin or another metabolite could be 
the major toxic principles in humans. 
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SUMMARY 
The trichothecenes, a group of toxic compounds produced by a 
variety of fungal species, have been associated with a number 
of human and animal diseases. They induce a wide spectrum of 
biological effects in experimental animals, including haemorrhaging, 
diarrhea, suppression of the immune system and disorders of the 
haematopoeitic system. 
This study involved the investigation of the effects of diacetoxy= 
scirpenol (DAS) and neosolaniol monoacetate (NMA), two of the most 
toxic trichothecenes, in rats. In order to conduct these studies, 
it was necessary to first purify NMA from fungal cultures. The 
toxin was isolated from rice cultures of F. sambucinum strain 
MRC 1903 and purified using solvent partitioning and silica gel 
column chromatography. The brine shrimp toxicity test as well 
as TLC and GC analysis were used for monitoring the toxin. The 
identity and purity of the NMA were assessed by melting point 
determination, GC analysis and mass spectroscopy. 
Treatment of male Wistar rats with DAS and NMA resulted in a 
significant decrease in red blood cell counts (P <0.05) and an 
increase in platelet size (P <0.05). The white blood cell popu= 
lation and platelet levels were however not significantly affected. 
Atrophy of the actively dividing cells of the bone marrow, thymus, 
spleen and lymph nodes was the major pathological lesion, but 
showed signs of recovery towards the end of the treatment period. 
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The toxicities of the trichothecenes are known to differ in various 
animal species. To investigate this phenomenon, the metabolism 
of another highly toxic trichothecene, T-2 toxin, was studied using 
rat, ca~ human and monkey hepatic microsomes. T-2 toxin was 
shown to be a substrate for the microsomal esterases. The deacy= 
lation rate differed considerably between the microsomal prepara= 
tions from the different species. The highest deacylation rate 
under similar in vitro conditions was observed with human, 
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followed in decreasing order by rat, cat and monkey microsomes. The 
latter two exhibited allosteric behaviour. The higher deacylation 
rate observed with rat compared to that of cat and monkey correlates 
with the known toxicity of T-2 toxin in these animal species, i.e. 
the higher the deacylation rate the lower the toxicity. 
Studies were conducted to investigate the possible role of the 
UDP-glucuronyltransferases in the metabolism of T-2 toxin. 
Neither T-2 toxin nor its metabolites, HT-2 toxin and T-2 tetraol, 
appear to act as substrates for the enzymes in rat and pig 
hepatic microsomes under the experimental conditions used in this 
study. 
Studies on the metabolic fate of trichothecenes could contribute 
to a better understanding of the difference in toxicity in various 
species. The extrapolation of the toxicity from one species to 
another should therefore be undertaken with great circumspection. 
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